Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata4
|
ENSMUSG00000021944.9 | GATA binding protein 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_63231380_63231561 | Gata4 | 13778 | 0.159294 | 0.70 | 3.8e-09 | Click! |
chr14_63212292_63212443 | Gata4 | 1240 | 0.410160 | 0.61 | 7.7e-07 | Click! |
chr14_63270775_63270926 | Gata4 | 274 | 0.906825 | 0.60 | 1.2e-06 | Click! |
chr14_63245931_63246206 | Gata4 | 797 | 0.619165 | 0.59 | 2.5e-06 | Click! |
chr14_63270982_63271133 | Gata4 | 67 | 0.971932 | 0.58 | 3.9e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_101995493_101995671 | 128.36 |
Gm31326 |
predicted gene, 31326 |
6322 |
0.2 |
chr7_80542454_80542814 | 123.22 |
Blm |
Bloom syndrome, RecQ like helicase |
7515 |
0.17 |
chr6_122394205_122394556 | 87.28 |
1700063H04Rik |
RIKEN cDNA 1700063H04 gene |
3001 |
0.17 |
chr6_29699578_29699733 | 86.16 |
Tspan33 |
tetraspanin 33 |
5421 |
0.19 |
chr11_61075462_61075620 | 85.60 |
Kcnj12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
9737 |
0.17 |
chr11_102895930_102896093 | 84.11 |
Gfap |
glial fibrillary acidic protein |
1120 |
0.32 |
chr1_193001497_193001909 | 82.22 |
Syt14 |
synaptotagmin XIV |
33941 |
0.13 |
chr10_77159583_77159894 | 80.49 |
Col18a1 |
collagen, type XVIII, alpha 1 |
6810 |
0.2 |
chr10_59348214_59348567 | 77.31 |
P4ha1 |
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide |
25022 |
0.16 |
chr6_56920853_56921008 | 77.00 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
2794 |
0.17 |
chr17_12204944_12205677 | 76.69 |
Agpat4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) |
9815 |
0.17 |
chr15_100738414_100738782 | 76.60 |
I730030J21Rik |
RIKEN cDNA I730030J21 gene |
5861 |
0.13 |
chr4_154023722_154024341 | 75.89 |
Smim1 |
small integral membrane protein 1 |
292 |
0.82 |
chr18_34519493_34519793 | 74.92 |
n-R5s24 |
nuclear encoded rRNA 5S 24 |
9906 |
0.14 |
chr11_87726236_87726559 | 74.79 |
Rnf43 |
ring finger protein 43 |
1029 |
0.34 |
chr12_24889410_24890042 | 74.75 |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
58095 |
0.09 |
chr2_32128159_32128364 | 72.39 |
Prrc2b |
proline-rich coiled-coil 2B |
22821 |
0.1 |
chr17_25089285_25089469 | 72.35 |
Ift140 |
intraflagellar transport 140 |
1294 |
0.29 |
chr19_11725919_11726212 | 71.87 |
Cblif |
cobalamin binding intrinsic factor |
21489 |
0.08 |
chr7_118143758_118143917 | 71.80 |
Smg1 |
SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) |
2038 |
0.26 |
chr11_96926664_96926823 | 71.52 |
Prr15l |
proline rich 15-like |
1361 |
0.23 |
chr15_80910888_80911184 | 71.03 |
Tnrc6b |
trinucleotide repeat containing 6b |
4880 |
0.17 |
chr9_48362196_48362510 | 70.70 |
Nxpe4 |
neurexophilin and PC-esterase domain family, member 4 |
312 |
0.89 |
chr18_34410163_34410637 | 69.16 |
Pkd2l2 |
polycystic kidney disease 2-like 2 |
974 |
0.53 |
chr2_167043430_167043751 | 68.86 |
Znfx1 |
zinc finger, NFX1-type containing 1 |
95 |
0.93 |
chr11_95356559_95356764 | 67.96 |
Fam117a |
family with sequence similarity 117, member A |
16699 |
0.11 |
chr14_27349855_27350152 | 67.33 |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
11386 |
0.2 |
chr12_32104526_32104851 | 67.16 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
19014 |
0.16 |
chr15_62223170_62223510 | 66.61 |
Pvt1 |
Pvt1 oncogene |
737 |
0.72 |
chr11_11815892_11816057 | 65.96 |
Ddc |
dopa decarboxylase |
6947 |
0.19 |
chr2_6263938_6264314 | 65.05 |
Gm13383 |
predicted gene 13383 |
6860 |
0.19 |
chr11_31843822_31844223 | 64.79 |
Gm12107 |
predicted gene 12107 |
11362 |
0.18 |
chr3_98855197_98855511 | 64.74 |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
4440 |
0.12 |
chr18_63727962_63728274 | 64.49 |
Wdr7 |
WD repeat domain 7 |
10946 |
0.16 |
chr16_29845675_29845975 | 64.40 |
Gm32679 |
predicted gene, 32679 |
11097 |
0.21 |
chr17_84926246_84926536 | 63.99 |
Gm49982 |
predicted gene, 49982 |
23822 |
0.14 |
chr7_133552409_133552576 | 63.83 |
Tex36 |
testis expressed 36 |
49666 |
0.11 |
chr16_75917877_75918040 | 63.69 |
Samsn1 |
SAM domain, SH3 domain and nuclear localization signals, 1 |
8648 |
0.26 |
chr1_73038611_73038795 | 63.57 |
1700027A15Rik |
RIKEN cDNA 1700027A15 gene |
14134 |
0.22 |
chr8_83215030_83215277 | 62.74 |
Tbc1d9 |
TBC1 domain family, member 9 |
44106 |
0.11 |
chr1_134426409_134426588 | 62.46 |
Platr1 |
pluripotency associated transcript 1 |
9130 |
0.1 |
chr5_22348437_22348700 | 62.02 |
Reln |
reelin |
3866 |
0.17 |
chr9_66182054_66182393 | 61.43 |
Dapk2 |
death-associated protein kinase 2 |
23988 |
0.17 |
chr2_84051878_84052087 | 61.43 |
Gm13692 |
predicted gene 13692 |
17369 |
0.15 |
chr3_100547585_100547929 | 61.15 |
Gm43466 |
predicted gene 43466 |
39770 |
0.11 |
chr2_121037044_121037214 | 61.05 |
Epb42 |
erythrocyte membrane protein band 4.2 |
57 |
0.95 |
chr6_120216773_120216945 | 60.95 |
Ninj2 |
ninjurin 2 |
23036 |
0.17 |
chr8_122321694_122322027 | 60.75 |
Zfpm1 |
zinc finger protein, multitype 1 |
11838 |
0.12 |
chr5_115626548_115626814 | 60.41 |
1110006O24Rik |
RIKEN cDNA 1110006O24 gene |
5135 |
0.11 |
chr19_31781133_31781545 | 59.79 |
Prkg1 |
protein kinase, cGMP-dependent, type I |
16306 |
0.26 |
chr13_119232480_119232644 | 59.61 |
Gm44488 |
predicted gene, 44488 |
37042 |
0.17 |
chr3_137969141_137969487 | 59.06 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
12216 |
0.12 |
chr2_29683306_29683623 | 58.94 |
Rapgef1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
19018 |
0.15 |
chr8_122685516_122685815 | 58.92 |
Gm15899 |
predicted gene 15899 |
1826 |
0.21 |
chr15_67151184_67151505 | 58.90 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
22321 |
0.23 |
chr10_61123577_61123747 | 58.76 |
Gm44308 |
predicted gene, 44308 |
1573 |
0.32 |
chr16_17871486_17871655 | 58.76 |
Dgcr2 |
DiGeorge syndrome critical region gene 2 |
20023 |
0.07 |
chr17_25127767_25127933 | 58.68 |
Clcn7 |
chloride channel, voltage-sensitive 7 |
5541 |
0.1 |
chr7_120875272_120875461 | 58.33 |
Gm15774 |
predicted gene 15774 |
68 |
0.93 |
chr12_83579151_83579469 | 58.16 |
Zfyve1 |
zinc finger, FYVE domain containing 1 |
16377 |
0.14 |
chr13_34828020_34828310 | 58.15 |
Gm47157 |
predicted gene, 47157 |
13621 |
0.13 |
chr12_82700835_82701146 | 58.05 |
Rgs6 |
regulator of G-protein signaling 6 |
49161 |
0.15 |
chr12_79985443_79985610 | 57.74 |
Gm8275 |
predicted gene 8275 |
5675 |
0.21 |
chr10_94047858_94048136 | 57.61 |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
11996 |
0.12 |
chr5_142638000_142638229 | 57.33 |
Wipi2 |
WD repeat domain, phosphoinositide interacting 2 |
8521 |
0.16 |
chr15_76808463_76808769 | 57.28 |
Arhgap39 |
Rho GTPase activating protein 39 |
9354 |
0.11 |
chr15_96928759_96928920 | 57.12 |
Rpl10a-ps3 |
ribosomal protein L10A, pseudogene 3 |
5434 |
0.3 |
chr9_32098893_32099046 | 56.85 |
Arhgap32 |
Rho GTPase activating protein 32 |
17167 |
0.15 |
chr2_15163820_15164009 | 56.85 |
Gm13313 |
predicted gene 13313 |
36314 |
0.17 |
chr15_88761742_88761940 | 56.65 |
Zbed4 |
zinc finger, BED type containing 4 |
10081 |
0.16 |
chr1_185515526_185516243 | 56.65 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
18496 |
0.17 |
chr9_124138054_124138419 | 56.56 |
Ccr5 |
chemokine (C-C motif) receptor 5 |
9488 |
0.21 |
chr6_122393389_122393560 | 56.49 |
1700063H04Rik |
RIKEN cDNA 1700063H04 gene |
2095 |
0.22 |
chr11_32256230_32256421 | 56.33 |
Nprl3 |
nitrogen permease regulator-like 3 |
88 |
0.94 |
chrX_162470321_162470491 | 55.57 |
Reps2 |
RALBP1 associated Eps domain containing protein 2 |
82173 |
0.08 |
chr11_45805281_45805840 | 55.55 |
F630206G17Rik |
RIKEN cDNA F630206G17 gene |
2527 |
0.22 |
chr10_98625072_98625237 | 55.50 |
Gm5427 |
predicted gene 5427 |
74556 |
0.11 |
chr5_139734130_139734319 | 55.25 |
Micall2 |
MICAL-like 2 |
1390 |
0.34 |
chr19_40813516_40813688 | 55.12 |
Ccnj |
cyclin J |
17677 |
0.16 |
chr3_133624021_133624348 | 55.08 |
Gm37228 |
predicted gene, 37228 |
10574 |
0.17 |
chr15_9080371_9080554 | 55.04 |
Nadk2 |
NAD kinase 2, mitochondrial |
5185 |
0.24 |
chr9_98314165_98314344 | 54.93 |
Gm28530 |
predicted gene 28530 |
12604 |
0.2 |
chr12_84358813_84358964 | 54.74 |
Coq6 |
coenzyme Q6 monooxygenase |
2769 |
0.15 |
chr4_46023185_46023394 | 54.74 |
Tdrd7 |
tudor domain containing 7 |
2812 |
0.27 |
chr5_36736135_36736430 | 54.71 |
Gm43701 |
predicted gene 43701 |
12336 |
0.12 |
chr14_46536141_46536312 | 54.67 |
Gm48912 |
predicted gene, 48912 |
19784 |
0.11 |
chr2_71073920_71074109 | 54.41 |
Dcaf17 |
DDB1 and CUL4 associated factor 17 |
1328 |
0.46 |
chr11_29814877_29815214 | 54.24 |
Eml6 |
echinoderm microtubule associated protein like 6 |
6617 |
0.16 |
chrX_7971365_7971849 | 54.15 |
Gata1 |
GATA binding protein 1 |
3697 |
0.1 |
chr2_15121492_15121674 | 54.13 |
Gm13313 |
predicted gene 13313 |
6017 |
0.21 |
chr17_48272064_48272554 | 54.01 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
130 |
0.94 |
chr13_112672887_112673076 | 53.78 |
Slc38a9 |
solute carrier family 38, member 9 |
4610 |
0.16 |
chr8_13202926_13203099 | 53.65 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
2192 |
0.16 |
chr17_78328309_78328607 | 53.56 |
Crim1 |
cysteine rich transmembrane BMP regulator 1 (chordin like) |
22431 |
0.16 |
chr18_5390246_5390643 | 53.55 |
Gm50065 |
predicted gene, 50065 |
19962 |
0.19 |
chr14_70713082_70713272 | 53.54 |
Xpo7 |
exportin 7 |
5142 |
0.18 |
chr6_38910607_38911206 | 53.51 |
Tbxas1 |
thromboxane A synthase 1, platelet |
8074 |
0.21 |
chr6_83351875_83352076 | 53.48 |
Bola3 |
bolA-like 3 (E. coli) |
120 |
0.94 |
chr10_3993751_3994053 | 53.12 |
Gm16074 |
predicted gene 16074 |
1531 |
0.36 |
chr15_62099349_62099519 | 53.04 |
Pvt1 |
Pvt1 oncogene |
405 |
0.91 |
chr1_160825617_160825795 | 52.94 |
Gm38060 |
predicted gene, 38060 |
13462 |
0.11 |
chr19_43453054_43453237 | 52.85 |
Gm47936 |
predicted gene, 47936 |
12685 |
0.13 |
chr1_184645271_184645605 | 52.78 |
Gm37800 |
predicted gene, 37800 |
15965 |
0.15 |
chr19_56391765_56391943 | 52.74 |
Nrap |
nebulin-related anchoring protein |
1817 |
0.31 |
chr4_141161724_141161914 | 52.64 |
Fbxo42 |
F-box protein 42 |
13897 |
0.11 |
chr7_24371478_24371804 | 52.59 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
1303 |
0.24 |
chr12_113107508_113107673 | 52.52 |
Mta1 |
metastasis associated 1 |
9189 |
0.11 |
chr8_117089920_117090087 | 52.49 |
Bco1 |
beta-carotene oxygenase 1 |
5851 |
0.17 |
chr7_141770985_141771320 | 52.43 |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
17820 |
0.15 |
chr7_81719355_81719657 | 52.26 |
Homer2 |
homer scaffolding protein 2 |
11979 |
0.12 |
chr13_32993547_32993707 | 52.18 |
Gm47662 |
predicted gene, 47662 |
3435 |
0.16 |
chr17_42884465_42884760 | 52.15 |
Cd2ap |
CD2-associated protein |
7947 |
0.29 |
chr19_60872283_60872608 | 52.01 |
Prdx3 |
peroxiredoxin 3 |
2111 |
0.23 |
chr9_14369323_14369628 | 52.00 |
Endod1 |
endonuclease domain containing 1 |
11508 |
0.12 |
chr9_70926847_70927150 | 51.79 |
Gm32017 |
predicted gene, 32017 |
3490 |
0.25 |
chr14_20599676_20599956 | 51.78 |
Usp54 |
ubiquitin specific peptidase 54 |
5514 |
0.13 |
chr5_116026678_116026866 | 51.65 |
Gm13842 |
predicted gene 13842 |
2064 |
0.2 |
chr9_103288259_103288431 | 51.59 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
48 |
0.97 |
chr7_51991063_51991344 | 51.35 |
Svip |
small VCP/p97-interacting protein |
14495 |
0.16 |
chr13_118629682_118629962 | 51.32 |
Gm10732 |
predicted gene 10732 |
28921 |
0.13 |
chr13_95474309_95474561 | 51.27 |
S100z |
S100 calcium binding protein, zeta |
4286 |
0.19 |
chr19_17323425_17323682 | 51.25 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
11883 |
0.21 |
chr1_131126323_131126498 | 51.23 |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
11835 |
0.13 |
chr11_98580301_98580503 | 51.07 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
6966 |
0.11 |
chr7_103877202_103877483 | 51.02 |
Olfr66 |
olfactory receptor 66 |
4899 |
0.07 |
chr7_99594452_99594625 | 50.77 |
Arrb1 |
arrestin, beta 1 |
55 |
0.96 |
chr1_77281437_77282151 | 50.57 |
Epha4 |
Eph receptor A4 |
95813 |
0.08 |
chr1_170610404_170610568 | 50.41 |
Gm7299 |
predicted gene 7299 |
20435 |
0.16 |
chr6_87740576_87740855 | 50.23 |
Efcc1 |
EF hand and coiled-coil domain containing 1 |
7906 |
0.09 |
chr4_133247843_133248221 | 50.21 |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
754 |
0.51 |
chr4_42880247_42880414 | 50.11 |
Fam205c |
family with sequence similarity 205, member C |
6096 |
0.14 |
chr11_102363647_102363997 | 50.02 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
118 |
0.93 |
chr11_64509196_64509472 | 49.98 |
Hs3st3a1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
74002 |
0.11 |
chr17_88466687_88466847 | 49.96 |
Foxn2 |
forkhead box N2 |
25992 |
0.16 |
chr6_31612964_31613142 | 49.88 |
Gm43154 |
predicted gene 43154 |
7764 |
0.19 |
chr12_111443494_111443821 | 49.84 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
667 |
0.58 |
chr8_117766047_117766202 | 49.49 |
Gm31774 |
predicted gene, 31774 |
17864 |
0.14 |
chr17_84776723_84776893 | 49.48 |
Lrpprc |
leucine-rich PPR-motif containing |
735 |
0.64 |
chr14_86742206_86742485 | 49.28 |
Diaph3 |
diaphanous related formin 3 |
6499 |
0.26 |
chr2_27981631_27981939 | 49.19 |
Col5a1 |
collagen, type V, alpha 1 |
35656 |
0.15 |
chr1_170622997_170623376 | 49.04 |
Gm7299 |
predicted gene 7299 |
7735 |
0.19 |
chr7_115830920_115831237 | 49.02 |
Sox6 |
SRY (sex determining region Y)-box 6 |
6368 |
0.31 |
chr3_100438511_100438708 | 49.00 |
Gm43121 |
predicted gene 43121 |
775 |
0.58 |
chr6_38923891_38924412 | 48.98 |
Tbxas1 |
thromboxane A synthase 1, platelet |
5127 |
0.23 |
chr16_32509635_32510013 | 48.95 |
Zdhhc19 |
zinc finger, DHHC domain containing 19 |
10213 |
0.13 |
chr5_24979632_24979791 | 48.89 |
1500035N22Rik |
RIKEN cDNA 1500035N22 gene |
6131 |
0.19 |
chr10_62327543_62328005 | 48.85 |
Hk1 |
hexokinase 1 |
7 |
0.97 |
chr16_35856803_35857099 | 48.83 |
Gm49730 |
predicted gene, 49730 |
11000 |
0.11 |
chr2_33843200_33843519 | 48.76 |
Nron |
non-protein coding RNA, repressor of NFAT |
37500 |
0.15 |
chr11_11729316_11729485 | 48.72 |
Gm12000 |
predicted gene 12000 |
32961 |
0.14 |
chr1_166812014_166812333 | 48.53 |
Gm37904 |
predicted gene, 37904 |
13334 |
0.22 |
chr6_120956690_120957084 | 48.48 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
836 |
0.46 |
chr17_28832918_28833228 | 48.38 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
4991 |
0.11 |
chr6_72384008_72384159 | 48.31 |
Vamp5 |
vesicle-associated membrane protein 5 |
3615 |
0.12 |
chr7_111179367_111179913 | 48.28 |
1700012D14Rik |
RIKEN cDNA 1700012D14 gene |
56956 |
0.11 |
chr15_97379586_97379766 | 48.28 |
Pced1b |
PC-esterase domain containing 1B |
18459 |
0.24 |
chr13_45130524_45130902 | 48.16 |
Gm40932 |
predicted gene, 40932 |
23820 |
0.16 |
chr10_54038165_54038485 | 48.11 |
Gm47917 |
predicted gene, 47917 |
25486 |
0.18 |
chr12_80036040_80036198 | 47.95 |
Gm36660 |
predicted gene, 36660 |
45315 |
0.1 |
chr9_121426584_121426749 | 47.88 |
Trak1 |
trafficking protein, kinesin binding 1 |
10691 |
0.19 |
chr11_4543369_4543542 | 47.87 |
Mtmr3 |
myotubularin related protein 3 |
2813 |
0.24 |
chr5_118488782_118489619 | 47.86 |
Gm15754 |
predicted gene 15754 |
2233 |
0.32 |
chr11_29504501_29504812 | 47.86 |
Prorsd1 |
prolyl-tRNA synthetase domain containing 1 |
10375 |
0.11 |
chr9_71146317_71146483 | 47.75 |
Aqp9 |
aquaporin 9 |
16233 |
0.17 |
chr16_21357453_21357784 | 47.63 |
Magef1 |
melanoma antigen family F, 1 |
24262 |
0.18 |
chr2_153260434_153260603 | 47.62 |
Pofut1 |
protein O-fucosyltransferase 1 |
2946 |
0.19 |
chr4_133879094_133879516 | 47.59 |
Gm12985 |
predicted gene 12985 |
3822 |
0.14 |
chr15_50507778_50508378 | 47.56 |
Gm49198 |
predicted gene, 49198 |
221180 |
0.02 |
chr12_27680639_27680801 | 47.54 |
Gm24326 |
predicted gene, 24326 |
48917 |
0.17 |
chr6_120832115_120832382 | 47.51 |
Bcl2l13 |
BCL2-like 13 (apoptosis facilitator) |
3964 |
0.17 |
chr12_76241275_76241437 | 47.34 |
Tex21 |
testis expressed gene 21 |
5329 |
0.14 |
chr5_73191818_73192155 | 47.16 |
Fryl |
FRY like transcription coactivator |
107 |
0.94 |
chr8_94899227_94899584 | 47.10 |
Ccdc102a |
coiled-coil domain containing 102A |
18116 |
0.1 |
chr19_4859073_4859231 | 46.98 |
Ctsf |
cathepsin F |
141 |
0.89 |
chr1_133754351_133754516 | 46.84 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
686 |
0.63 |
chr1_179808385_179808545 | 46.79 |
Ahctf1 |
AT hook containing transcription factor 1 |
4785 |
0.21 |
chr4_120630429_120630582 | 46.76 |
Gm12860 |
predicted gene 12860 |
14665 |
0.13 |
chr2_146099017_146099372 | 46.70 |
Cfap61 |
cilia and flagella associated protein 61 |
51943 |
0.15 |
chr1_77298700_77298868 | 46.69 |
Epha4 |
Eph receptor A4 |
78823 |
0.11 |
chr18_62110973_62111139 | 46.59 |
Gm41750 |
predicted gene, 41750 |
31562 |
0.18 |
chr7_142419946_142420107 | 46.59 |
Gm26143 |
predicted gene, 26143 |
4769 |
0.11 |
chr15_36648029_36648244 | 46.56 |
Gm6704 |
predicted gene 6704 |
18267 |
0.12 |
chr18_78335711_78335874 | 46.55 |
Gm6133 |
predicted gene 6133 |
13962 |
0.27 |
chr7_103859191_103859473 | 46.53 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
6116 |
0.06 |
chr15_83592885_83593046 | 46.45 |
Ttll12 |
tubulin tyrosine ligase-like family, member 12 |
2192 |
0.23 |
chr5_23922914_23923135 | 46.43 |
Fam126a |
family with sequence similarity 126, member A |
120 |
0.95 |
chr13_97778107_97778371 | 46.36 |
Gm47577 |
predicted gene, 47577 |
12325 |
0.14 |
chr4_109411064_109411374 | 46.32 |
Ttc39a |
tetratricopeptide repeat domain 39A |
3557 |
0.19 |
chr18_39380667_39381030 | 46.29 |
Gm15337 |
predicted gene 15337 |
8577 |
0.2 |
chr17_84728549_84728791 | 46.26 |
Lrpprc |
leucine-rich PPR-motif containing |
2514 |
0.25 |
chr7_133563294_133563459 | 46.22 |
Tex36 |
testis expressed 36 |
38782 |
0.12 |
chr4_139179928_139180623 | 46.19 |
Gm16287 |
predicted gene 16287 |
380 |
0.82 |
chr9_50824223_50824405 | 46.16 |
Alg9 |
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase) |
1271 |
0.37 |
chr18_68230237_68230503 | 46.13 |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
2303 |
0.29 |
chr14_69276372_69276540 | 46.10 |
Gm20236 |
predicted gene, 20236 |
5684 |
0.1 |
chr14_69494622_69494790 | 46.10 |
Gm37094 |
predicted gene, 37094 |
5684 |
0.11 |
chr14_74673659_74673991 | 46.03 |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A |
32985 |
0.16 |
chr16_4896345_4896511 | 46.02 |
Mgrn1 |
mahogunin, ring finger 1 |
10042 |
0.11 |
chr13_101573406_101573557 | 46.01 |
Gm19010 |
predicted gene, 19010 |
15650 |
0.16 |
chr2_156783409_156783580 | 45.89 |
Myl9 |
myosin, light polypeptide 9, regulatory |
4977 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
35.5 | 106.5 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
32.1 | 96.3 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
25.3 | 101.4 | GO:0032264 | IMP salvage(GO:0032264) |
25.1 | 25.1 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
23.2 | 92.8 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
22.5 | 112.6 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
21.7 | 108.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
21.3 | 21.3 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
21.0 | 104.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
20.8 | 103.8 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
20.5 | 102.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
20.1 | 60.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
20.0 | 80.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
18.0 | 54.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
17.9 | 53.7 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
17.8 | 89.2 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
17.5 | 52.5 | GO:0036394 | amylase secretion(GO:0036394) |
16.7 | 66.8 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
15.8 | 15.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
14.8 | 44.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
14.7 | 73.7 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
14.4 | 114.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
14.2 | 42.5 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
14.1 | 42.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
13.8 | 82.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
13.8 | 41.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
13.8 | 27.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
13.6 | 67.9 | GO:0070836 | caveola assembly(GO:0070836) |
13.5 | 270.8 | GO:0048821 | erythrocyte development(GO:0048821) |
13.4 | 67.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
13.4 | 40.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
13.4 | 40.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
13.3 | 66.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
13.3 | 39.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
13.1 | 39.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
12.8 | 38.5 | GO:0061511 | centriole elongation(GO:0061511) |
12.3 | 61.6 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
12.2 | 36.5 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
12.1 | 60.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
12.1 | 36.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
12.1 | 84.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
12.0 | 48.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
11.8 | 11.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
11.7 | 35.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
11.7 | 35.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
11.7 | 58.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
11.5 | 45.9 | GO:0018343 | protein farnesylation(GO:0018343) |
11.2 | 45.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
11.2 | 56.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
11.2 | 33.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
11.2 | 44.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
11.1 | 44.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
11.1 | 11.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
10.9 | 32.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
10.9 | 21.9 | GO:0018992 | germ-line sex determination(GO:0018992) |
10.9 | 21.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
10.7 | 96.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
10.7 | 32.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
10.6 | 31.7 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
10.5 | 31.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
10.4 | 31.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
10.4 | 83.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
10.4 | 52.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
10.4 | 31.1 | GO:0008050 | female courtship behavior(GO:0008050) |
10.2 | 71.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
10.2 | 81.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
10.1 | 40.5 | GO:0097460 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
10.1 | 10.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
9.8 | 19.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
9.8 | 88.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
9.7 | 58.4 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
9.7 | 38.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
9.7 | 9.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
9.7 | 29.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
9.6 | 28.8 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
9.5 | 28.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
9.5 | 37.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
9.5 | 28.4 | GO:0070669 | response to interleukin-2(GO:0070669) |
9.4 | 37.7 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
9.2 | 64.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
9.2 | 156.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
9.2 | 55.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
9.2 | 36.6 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
9.1 | 27.4 | GO:0042117 | monocyte activation(GO:0042117) |
9.0 | 36.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
9.0 | 26.9 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
9.0 | 26.9 | GO:0040031 | snRNA modification(GO:0040031) |
8.9 | 26.7 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
8.8 | 52.9 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
8.8 | 35.3 | GO:0050904 | diapedesis(GO:0050904) |
8.6 | 34.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
8.6 | 59.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
8.4 | 50.5 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
8.3 | 181.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
8.2 | 32.7 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
8.1 | 16.3 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
8.1 | 48.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
8.1 | 8.1 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
8.1 | 16.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
8.1 | 24.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
8.1 | 32.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
8.0 | 88.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
8.0 | 23.9 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
7.9 | 15.8 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
7.9 | 15.8 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
7.9 | 23.6 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
7.9 | 39.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
7.8 | 85.8 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
7.7 | 30.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
7.6 | 7.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
7.6 | 30.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
7.5 | 22.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
7.5 | 22.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
7.5 | 67.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
7.5 | 7.5 | GO:0031643 | positive regulation of myelination(GO:0031643) |
7.4 | 29.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
7.4 | 22.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
7.3 | 29.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
7.3 | 36.5 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
7.3 | 43.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
7.3 | 29.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
7.3 | 79.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
7.2 | 43.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
7.2 | 21.5 | GO:0008228 | opsonization(GO:0008228) |
7.2 | 28.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
7.2 | 21.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
7.1 | 7.1 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
7.1 | 35.5 | GO:0015671 | oxygen transport(GO:0015671) |
7.1 | 21.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
7.0 | 7.0 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
7.0 | 35.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
7.0 | 7.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
7.0 | 20.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
6.9 | 20.7 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
6.9 | 41.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
6.9 | 20.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
6.8 | 6.8 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
6.8 | 34.2 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
6.8 | 61.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
6.8 | 27.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
6.8 | 34.0 | GO:0009642 | response to light intensity(GO:0009642) |
6.8 | 20.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
6.8 | 20.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
6.7 | 74.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
6.7 | 20.2 | GO:0042938 | dipeptide transport(GO:0042938) |
6.7 | 20.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
6.6 | 6.6 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
6.6 | 13.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
6.6 | 19.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
6.6 | 26.4 | GO:0003383 | apical constriction(GO:0003383) |
6.6 | 19.7 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
6.6 | 13.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
6.6 | 6.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
6.5 | 13.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
6.5 | 19.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
6.5 | 19.4 | GO:0001555 | oocyte growth(GO:0001555) |
6.5 | 25.8 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
6.4 | 19.3 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
6.4 | 19.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
6.4 | 19.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
6.4 | 12.7 | GO:0032898 | neurotrophin production(GO:0032898) |
6.3 | 19.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
6.3 | 76.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
6.3 | 107.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
6.3 | 25.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
6.3 | 12.6 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
6.3 | 69.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
6.2 | 12.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
6.2 | 18.6 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
6.2 | 12.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
6.2 | 18.6 | GO:1903416 | response to glycoside(GO:1903416) |
6.2 | 74.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
6.2 | 12.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
6.1 | 12.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
6.1 | 24.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
6.1 | 49.0 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
6.1 | 24.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
6.1 | 6.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
6.0 | 36.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
6.0 | 18.1 | GO:0034214 | protein hexamerization(GO:0034214) |
6.0 | 24.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
6.0 | 12.0 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
6.0 | 18.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
6.0 | 29.9 | GO:0018101 | protein citrullination(GO:0018101) |
6.0 | 23.9 | GO:0097459 | iron ion import into cell(GO:0097459) |
5.9 | 41.5 | GO:0006547 | histidine metabolic process(GO:0006547) |
5.9 | 59.3 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
5.9 | 11.8 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
5.9 | 11.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
5.9 | 17.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
5.9 | 5.9 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
5.8 | 17.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
5.8 | 17.4 | GO:0000087 | mitotic M phase(GO:0000087) |
5.8 | 11.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
5.8 | 11.6 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
5.8 | 52.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
5.8 | 46.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
5.7 | 17.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
5.7 | 17.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
5.7 | 11.4 | GO:1902075 | cellular response to salt(GO:1902075) |
5.7 | 17.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
5.7 | 22.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
5.7 | 22.7 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
5.7 | 22.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
5.7 | 17.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
5.7 | 11.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
5.7 | 33.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
5.6 | 39.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
5.6 | 16.9 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
5.6 | 11.3 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
5.6 | 22.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
5.6 | 5.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
5.6 | 22.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
5.6 | 16.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
5.5 | 5.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
5.5 | 16.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
5.5 | 16.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
5.5 | 11.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
5.5 | 5.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
5.4 | 16.3 | GO:0032439 | endosome localization(GO:0032439) |
5.4 | 5.4 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
5.4 | 21.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
5.4 | 21.6 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
5.4 | 16.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
5.4 | 21.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
5.4 | 16.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
5.4 | 145.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
5.4 | 32.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
5.4 | 5.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
5.3 | 21.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
5.3 | 10.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
5.3 | 31.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
5.3 | 100.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
5.3 | 5.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
5.3 | 26.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
5.2 | 15.7 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
5.2 | 10.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
5.2 | 20.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
5.2 | 26.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
5.2 | 15.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
5.2 | 15.6 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
5.2 | 5.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
5.2 | 10.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
5.2 | 31.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
5.2 | 10.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
5.1 | 36.0 | GO:0034204 | lipid translocation(GO:0034204) |
5.1 | 118.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
5.1 | 5.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
5.1 | 10.3 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
5.1 | 15.4 | GO:0015677 | copper ion import(GO:0015677) |
5.1 | 10.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
5.1 | 15.3 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
5.1 | 10.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
5.1 | 25.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
5.0 | 45.4 | GO:0030449 | regulation of complement activation(GO:0030449) |
5.0 | 30.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
5.0 | 15.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
5.0 | 20.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
5.0 | 10.1 | GO:0072553 | terminal button organization(GO:0072553) |
5.0 | 5.0 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
5.0 | 25.0 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
5.0 | 15.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
5.0 | 19.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
5.0 | 5.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
5.0 | 9.9 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
4.9 | 39.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
4.9 | 29.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
4.9 | 4.9 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
4.9 | 14.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
4.9 | 19.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
4.9 | 24.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
4.9 | 48.8 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
4.9 | 34.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
4.9 | 4.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
4.8 | 43.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
4.8 | 33.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
4.8 | 24.1 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
4.8 | 24.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
4.8 | 19.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
4.8 | 67.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
4.8 | 9.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
4.8 | 4.8 | GO:0072718 | response to cisplatin(GO:0072718) |
4.8 | 23.8 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
4.8 | 33.3 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
4.8 | 19.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
4.7 | 9.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
4.7 | 9.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
4.7 | 47.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
4.7 | 14.1 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
4.7 | 9.3 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
4.6 | 23.1 | GO:0006116 | NADH oxidation(GO:0006116) |
4.6 | 13.8 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
4.6 | 4.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
4.6 | 9.1 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
4.6 | 18.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
4.6 | 36.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
4.6 | 4.6 | GO:1902065 | response to L-glutamate(GO:1902065) |
4.5 | 36.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
4.5 | 13.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
4.5 | 17.9 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
4.5 | 13.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
4.4 | 13.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
4.4 | 13.3 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
4.4 | 13.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
4.4 | 13.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
4.4 | 30.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
4.4 | 8.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
4.4 | 30.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
4.4 | 35.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
4.4 | 35.2 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
4.4 | 44.0 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
4.4 | 8.8 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
4.4 | 17.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
4.4 | 13.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
4.4 | 26.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
4.4 | 8.8 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
4.4 | 13.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
4.4 | 21.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
4.4 | 8.7 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
4.3 | 4.3 | GO:0046137 | negative regulation of vitamin metabolic process(GO:0046137) |
4.3 | 13.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
4.3 | 4.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
4.3 | 34.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
4.3 | 12.9 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
4.3 | 12.9 | GO:0019042 | viral latency(GO:0019042) |
4.3 | 12.9 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
4.3 | 64.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
4.3 | 4.3 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
4.3 | 12.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
4.3 | 8.6 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
4.3 | 21.4 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
4.3 | 17.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
4.3 | 4.3 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
4.3 | 42.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
4.3 | 51.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
4.2 | 12.7 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
4.2 | 4.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
4.2 | 12.7 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
4.2 | 63.2 | GO:0007141 | male meiosis I(GO:0007141) |
4.2 | 8.4 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
4.2 | 8.4 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
4.2 | 37.8 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
4.2 | 12.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
4.2 | 12.5 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
4.2 | 33.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
4.2 | 12.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
4.2 | 8.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
4.2 | 25.0 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
4.2 | 4.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
4.2 | 4.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
4.1 | 4.1 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
4.1 | 4.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
4.1 | 16.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
4.1 | 16.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
4.1 | 16.5 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
4.1 | 4.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
4.1 | 12.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
4.1 | 16.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
4.1 | 8.2 | GO:0002215 | defense response to nematode(GO:0002215) |
4.1 | 8.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
4.1 | 16.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
4.1 | 36.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
4.1 | 16.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
4.1 | 16.2 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
4.1 | 32.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
4.0 | 40.5 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
4.0 | 12.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
4.0 | 12.1 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
4.0 | 4.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
4.0 | 4.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
4.0 | 4.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
4.0 | 16.0 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
4.0 | 12.0 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
4.0 | 28.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
4.0 | 16.0 | GO:1903432 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
4.0 | 76.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
4.0 | 20.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
4.0 | 16.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
4.0 | 16.0 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
4.0 | 8.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
4.0 | 11.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
4.0 | 4.0 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
4.0 | 35.7 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
3.9 | 7.9 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
3.9 | 23.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
3.9 | 27.6 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
3.9 | 19.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
3.9 | 15.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
3.9 | 23.5 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
3.9 | 19.5 | GO:0002934 | desmosome organization(GO:0002934) |
3.9 | 7.8 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
3.9 | 19.5 | GO:1901660 | calcium ion export(GO:1901660) |
3.9 | 7.8 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
3.9 | 3.9 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
3.9 | 15.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
3.9 | 38.8 | GO:0019985 | translesion synthesis(GO:0019985) |
3.9 | 15.5 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
3.9 | 11.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
3.9 | 7.7 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
3.9 | 50.1 | GO:0006828 | manganese ion transport(GO:0006828) |
3.8 | 11.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
3.8 | 11.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
3.8 | 19.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
3.8 | 11.5 | GO:0009629 | response to gravity(GO:0009629) |
3.8 | 7.6 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
3.8 | 7.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
3.8 | 38.2 | GO:0015858 | nucleoside transport(GO:0015858) |
3.8 | 22.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
3.8 | 7.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
3.8 | 22.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
3.8 | 3.8 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
3.8 | 7.6 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
3.8 | 7.6 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
3.8 | 41.6 | GO:0051601 | exocyst localization(GO:0051601) |
3.8 | 7.6 | GO:0015884 | folic acid transport(GO:0015884) |
3.8 | 15.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
3.8 | 11.3 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
3.8 | 15.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
3.8 | 37.7 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
3.8 | 48.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
3.7 | 15.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
3.7 | 11.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
3.7 | 7.5 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
3.7 | 7.5 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
3.7 | 3.7 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
3.7 | 11.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
3.7 | 7.4 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
3.7 | 148.9 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
3.7 | 7.4 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
3.7 | 3.7 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
3.7 | 14.9 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
3.7 | 7.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
3.7 | 7.4 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
3.7 | 3.7 | GO:0046129 | purine nucleoside biosynthetic process(GO:0042451) purine ribonucleoside biosynthetic process(GO:0046129) |
3.7 | 3.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
3.7 | 29.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
3.7 | 25.8 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
3.7 | 11.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
3.7 | 7.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
3.7 | 7.4 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
3.7 | 11.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
3.7 | 3.7 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
3.7 | 29.3 | GO:0046697 | decidualization(GO:0046697) |
3.6 | 21.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
3.6 | 7.3 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
3.6 | 10.9 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
3.6 | 7.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
3.6 | 21.7 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
3.6 | 25.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
3.6 | 39.7 | GO:0032310 | prostaglandin secretion(GO:0032310) |
3.6 | 21.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
3.6 | 21.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
3.6 | 7.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
3.6 | 17.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
3.6 | 3.6 | GO:0010470 | regulation of gastrulation(GO:0010470) |
3.6 | 17.8 | GO:0090009 | primitive streak formation(GO:0090009) |
3.6 | 7.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
3.6 | 10.7 | GO:0046104 | thymidine metabolic process(GO:0046104) |
3.6 | 7.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
3.6 | 3.6 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
3.6 | 7.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
3.6 | 14.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
3.5 | 7.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
3.5 | 10.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
3.5 | 3.5 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
3.5 | 24.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
3.5 | 3.5 | GO:1902474 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
3.5 | 14.0 | GO:0044351 | macropinocytosis(GO:0044351) |
3.5 | 14.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
3.5 | 3.5 | GO:0071280 | cellular response to copper ion(GO:0071280) |
3.5 | 17.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
3.5 | 10.5 | GO:0045730 | respiratory burst(GO:0045730) |
3.5 | 7.0 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
3.5 | 17.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
3.5 | 17.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
3.5 | 17.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
3.5 | 10.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
3.5 | 6.9 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
3.5 | 13.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
3.5 | 3.5 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
3.5 | 13.8 | GO:0015886 | heme transport(GO:0015886) |
3.5 | 10.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
3.4 | 37.9 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
3.4 | 10.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
3.4 | 13.8 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
3.4 | 13.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
3.4 | 6.9 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
3.4 | 6.8 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
3.4 | 10.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
3.4 | 13.6 | GO:0021860 | pyramidal neuron development(GO:0021860) |
3.4 | 20.4 | GO:0051026 | chiasma assembly(GO:0051026) |
3.4 | 27.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
3.4 | 17.0 | GO:0033572 | transferrin transport(GO:0033572) |
3.4 | 13.6 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
3.4 | 30.5 | GO:0001675 | acrosome assembly(GO:0001675) |
3.4 | 3.4 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
3.4 | 13.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
3.4 | 13.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
3.4 | 13.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
3.4 | 23.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
3.4 | 10.1 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
3.4 | 13.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
3.4 | 13.4 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
3.3 | 6.7 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
3.3 | 16.7 | GO:0097320 | membrane tubulation(GO:0097320) |
3.3 | 6.7 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
3.3 | 13.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
3.3 | 20.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
3.3 | 6.6 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
3.3 | 3.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
3.3 | 16.6 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
3.3 | 6.6 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
3.3 | 6.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
3.3 | 23.2 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
3.3 | 16.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
3.3 | 16.5 | GO:0019695 | choline metabolic process(GO:0019695) |
3.3 | 19.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
3.3 | 49.5 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
3.3 | 3.3 | GO:0007144 | female meiosis I(GO:0007144) |
3.3 | 36.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
3.3 | 19.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
3.3 | 6.6 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
3.3 | 32.8 | GO:0006301 | postreplication repair(GO:0006301) |
3.3 | 3.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
3.3 | 3.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
3.3 | 6.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
3.3 | 3.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.2 | 29.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
3.2 | 6.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
3.2 | 19.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
3.2 | 51.7 | GO:0016075 | rRNA catabolic process(GO:0016075) |
3.2 | 16.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
3.2 | 12.8 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
3.2 | 16.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
3.2 | 6.4 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
3.2 | 6.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
3.2 | 6.4 | GO:0033194 | response to hydroperoxide(GO:0033194) |
3.2 | 19.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
3.2 | 22.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
3.2 | 3.2 | GO:0043217 | myelin maintenance(GO:0043217) |
3.2 | 25.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
3.2 | 12.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
3.2 | 3.2 | GO:0051591 | response to cAMP(GO:0051591) |
3.2 | 9.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
3.2 | 15.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
3.2 | 15.8 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
3.2 | 22.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
3.1 | 3.1 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
3.1 | 9.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
3.1 | 9.4 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
3.1 | 12.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
3.1 | 15.6 | GO:0033574 | response to testosterone(GO:0033574) |
3.1 | 3.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
3.1 | 18.8 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
3.1 | 28.1 | GO:0070269 | pyroptosis(GO:0070269) |
3.1 | 18.7 | GO:0015871 | choline transport(GO:0015871) |
3.1 | 12.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
3.1 | 9.4 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
3.1 | 6.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
3.1 | 9.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
3.1 | 6.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
3.1 | 49.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
3.1 | 12.4 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
3.1 | 27.9 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
3.1 | 9.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
3.1 | 12.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
3.1 | 9.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
3.1 | 15.4 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
3.1 | 43.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
3.1 | 3.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
3.1 | 6.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
3.1 | 6.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
3.1 | 21.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
3.1 | 107.6 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
3.1 | 9.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
3.1 | 6.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
3.1 | 24.6 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
3.1 | 9.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
3.1 | 3.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
3.1 | 6.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
3.0 | 18.3 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
3.0 | 21.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
3.0 | 9.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
3.0 | 3.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
3.0 | 6.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
3.0 | 9.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
3.0 | 9.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
3.0 | 9.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
3.0 | 3.0 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
3.0 | 6.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
3.0 | 12.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
3.0 | 15.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
3.0 | 12.0 | GO:0015705 | iodide transport(GO:0015705) |
3.0 | 9.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
3.0 | 6.0 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
3.0 | 50.7 | GO:0045047 | protein targeting to ER(GO:0045047) |
3.0 | 14.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
3.0 | 3.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
3.0 | 35.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
3.0 | 17.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
3.0 | 14.8 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
2.9 | 11.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
2.9 | 2.9 | GO:0042033 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
2.9 | 14.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
2.9 | 11.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
2.9 | 8.8 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.9 | 8.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
2.9 | 44.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
2.9 | 14.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
2.9 | 20.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
2.9 | 61.4 | GO:0032456 | endocytic recycling(GO:0032456) |
2.9 | 11.7 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
2.9 | 8.8 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
2.9 | 11.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
2.9 | 5.8 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
2.9 | 11.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
2.9 | 60.8 | GO:0032642 | regulation of chemokine production(GO:0032642) |
2.9 | 118.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
2.9 | 26.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
2.9 | 8.7 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
2.9 | 115.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
2.9 | 14.4 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
2.9 | 54.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
2.9 | 63.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
2.9 | 17.2 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
2.9 | 20.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
2.9 | 14.3 | GO:0009249 | protein lipoylation(GO:0009249) |
2.9 | 5.7 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
2.9 | 14.3 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
2.9 | 8.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.9 | 5.7 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
2.8 | 8.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
2.8 | 14.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
2.8 | 11.4 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
2.8 | 11.4 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
2.8 | 14.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
2.8 | 62.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
2.8 | 14.2 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
2.8 | 8.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
2.8 | 5.7 | GO:0061042 | vascular wound healing(GO:0061042) |
2.8 | 22.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
2.8 | 25.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
2.8 | 2.8 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
2.8 | 8.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
2.8 | 2.8 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
2.8 | 22.6 | GO:0032438 | melanosome organization(GO:0032438) |
2.8 | 5.6 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
2.8 | 19.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
2.8 | 36.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
2.8 | 2.8 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
2.8 | 8.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
2.8 | 8.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
2.8 | 2.8 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
2.8 | 8.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.8 | 2.8 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
2.8 | 11.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
2.7 | 11.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
2.7 | 16.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
2.7 | 13.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
2.7 | 2.7 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
2.7 | 8.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
2.7 | 13.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
2.7 | 8.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
2.7 | 2.7 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
2.7 | 5.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
2.7 | 2.7 | GO:0070459 | prolactin secretion(GO:0070459) |
2.7 | 18.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
2.7 | 32.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
2.7 | 2.7 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
2.7 | 21.4 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
2.7 | 10.7 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
2.7 | 31.9 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
2.7 | 5.3 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
2.7 | 5.3 | GO:0046959 | habituation(GO:0046959) |
2.7 | 13.3 | GO:0016266 | O-glycan processing(GO:0016266) |
2.7 | 10.6 | GO:1904355 | regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
2.7 | 8.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
2.6 | 2.6 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
2.6 | 2.6 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
2.6 | 13.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
2.6 | 2.6 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
2.6 | 5.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
2.6 | 23.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
2.6 | 23.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
2.6 | 15.7 | GO:0010039 | response to iron ion(GO:0010039) |
2.6 | 5.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
2.6 | 23.5 | GO:0031929 | TOR signaling(GO:0031929) |
2.6 | 2.6 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
2.6 | 5.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
2.6 | 98.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
2.6 | 7.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
2.6 | 2.6 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) |
2.6 | 7.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
2.6 | 12.9 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
2.6 | 12.9 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
2.6 | 2.6 | GO:0042891 | antibiotic transport(GO:0042891) |
2.6 | 33.3 | GO:0045576 | mast cell activation(GO:0045576) |
2.6 | 2.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
2.6 | 7.7 | GO:0015825 | L-serine transport(GO:0015825) |
2.5 | 7.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
2.5 | 7.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
2.5 | 27.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
2.5 | 12.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
2.5 | 20.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
2.5 | 15.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
2.5 | 7.6 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
2.5 | 7.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
2.5 | 10.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
2.5 | 25.2 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
2.5 | 7.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
2.5 | 15.0 | GO:0090151 | protein import into mitochondrial outer membrane(GO:0045040) establishment of protein localization to mitochondrial membrane(GO:0090151) |
2.5 | 17.5 | GO:0001659 | temperature homeostasis(GO:0001659) |
2.5 | 5.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
2.5 | 7.5 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
2.5 | 60.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
2.5 | 39.8 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
2.5 | 9.9 | GO:0042448 | progesterone metabolic process(GO:0042448) |
2.5 | 7.4 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
2.5 | 2.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.5 | 9.9 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
2.5 | 19.7 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
2.5 | 4.9 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
2.5 | 4.9 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
2.5 | 7.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
2.5 | 4.9 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
2.4 | 19.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
2.4 | 44.0 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
2.4 | 7.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.4 | 7.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
2.4 | 9.8 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
2.4 | 26.8 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
2.4 | 9.7 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
2.4 | 43.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
2.4 | 4.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.4 | 4.8 | GO:0030421 | defecation(GO:0030421) |
2.4 | 9.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
2.4 | 4.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
2.4 | 7.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
2.4 | 26.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
2.4 | 7.2 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
2.4 | 7.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
2.4 | 4.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
2.4 | 52.6 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
2.4 | 47.8 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
2.4 | 9.5 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
2.4 | 7.2 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
2.4 | 35.8 | GO:0006491 | N-glycan processing(GO:0006491) |
2.4 | 7.2 | GO:0033762 | response to glucagon(GO:0033762) |
2.4 | 9.5 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
2.4 | 11.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
2.4 | 4.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
2.4 | 23.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
2.4 | 2.4 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
2.4 | 4.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
2.4 | 2.4 | GO:0002606 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
2.4 | 2.4 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
2.4 | 4.7 | GO:0060631 | regulation of meiosis I(GO:0060631) |
2.4 | 11.8 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
2.4 | 7.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
2.3 | 4.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
2.3 | 23.5 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
2.3 | 4.7 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
2.3 | 56.2 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
2.3 | 7.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
2.3 | 7.0 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
2.3 | 13.9 | GO:0007343 | egg activation(GO:0007343) |
2.3 | 4.6 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
2.3 | 6.9 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
2.3 | 4.6 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
2.3 | 16.1 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
2.3 | 9.2 | GO:0045141 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic telomere clustering(GO:0045141) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
2.3 | 6.9 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
2.3 | 4.6 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
2.3 | 18.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
2.3 | 4.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
2.3 | 11.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
2.3 | 18.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
2.3 | 15.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
2.3 | 18.0 | GO:0070166 | enamel mineralization(GO:0070166) |
2.2 | 2.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
2.2 | 4.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
2.2 | 18.0 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
2.2 | 4.5 | GO:0006903 | vesicle targeting(GO:0006903) |
2.2 | 125.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
2.2 | 6.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
2.2 | 58.2 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
2.2 | 4.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
2.2 | 13.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
2.2 | 4.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
2.2 | 24.6 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
2.2 | 6.7 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
2.2 | 2.2 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
2.2 | 17.8 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
2.2 | 2.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
2.2 | 8.9 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
2.2 | 6.7 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
2.2 | 2.2 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
2.2 | 8.8 | GO:0051031 | tRNA transport(GO:0051031) |
2.2 | 2.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
2.2 | 6.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
2.2 | 22.0 | GO:0051383 | kinetochore organization(GO:0051383) |
2.2 | 4.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
2.2 | 2.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
2.2 | 6.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
2.2 | 2.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
2.2 | 19.7 | GO:0031639 | plasminogen activation(GO:0031639) |
2.2 | 6.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
2.2 | 8.7 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
2.2 | 8.7 | GO:0050957 | equilibrioception(GO:0050957) |
2.2 | 15.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
2.2 | 4.3 | GO:0042023 | DNA endoreduplication(GO:0042023) |
2.2 | 19.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
2.2 | 13.0 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
2.2 | 2.2 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
2.2 | 13.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
2.2 | 2.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
2.2 | 4.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
2.2 | 4.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
2.2 | 10.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
2.2 | 17.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
2.2 | 6.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
2.2 | 12.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
2.1 | 10.7 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
2.1 | 8.6 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
2.1 | 2.1 | GO:0060068 | vagina development(GO:0060068) |
2.1 | 2.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
2.1 | 12.8 | GO:0007000 | nucleolus organization(GO:0007000) |
2.1 | 2.1 | GO:0032692 | negative regulation of interleukin-1 production(GO:0032692) |
2.1 | 4.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
2.1 | 2.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
2.1 | 4.3 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
2.1 | 6.4 | GO:0032202 | telomere assembly(GO:0032202) |
2.1 | 8.5 | GO:0002021 | response to dietary excess(GO:0002021) |
2.1 | 8.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
2.1 | 4.2 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
2.1 | 4.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.1 | 2.1 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
2.1 | 6.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
2.1 | 4.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
2.1 | 4.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
2.1 | 10.5 | GO:0009650 | UV protection(GO:0009650) |
2.1 | 44.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
2.1 | 4.2 | GO:0048478 | replication fork protection(GO:0048478) |
2.1 | 12.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.1 | 4.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
2.1 | 6.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
2.1 | 6.3 | GO:0032914 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
2.1 | 6.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
2.1 | 6.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
2.1 | 2.1 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
2.1 | 2.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
2.1 | 20.8 | GO:0010842 | retina layer formation(GO:0010842) |
2.1 | 2.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
2.1 | 55.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
2.0 | 4.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
2.0 | 2.0 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
2.0 | 32.7 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
2.0 | 4.1 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
2.0 | 4.1 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
2.0 | 10.2 | GO:0015992 | proton transport(GO:0015992) |
2.0 | 8.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
2.0 | 4.1 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
2.0 | 2.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
2.0 | 22.3 | GO:0000154 | rRNA modification(GO:0000154) |
2.0 | 18.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
2.0 | 2.0 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
2.0 | 4.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.0 | 24.0 | GO:0045116 | protein neddylation(GO:0045116) |
2.0 | 29.9 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
2.0 | 4.0 | GO:0006868 | glutamine transport(GO:0006868) |
2.0 | 9.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
2.0 | 2.0 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
2.0 | 13.9 | GO:0046415 | urate metabolic process(GO:0046415) |
2.0 | 11.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
2.0 | 5.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
2.0 | 25.7 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
2.0 | 13.8 | GO:0009303 | rRNA transcription(GO:0009303) |
2.0 | 5.9 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.0 | 3.9 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
2.0 | 37.2 | GO:0007052 | mitotic spindle organization(GO:0007052) |
2.0 | 2.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
2.0 | 2.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.9 | 1.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.9 | 1.9 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
1.9 | 5.8 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.9 | 5.8 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
1.9 | 64.2 | GO:0030042 | actin filament depolymerization(GO:0030042) |
1.9 | 1.9 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
1.9 | 7.8 | GO:0070417 | cellular response to cold(GO:0070417) |
1.9 | 3.9 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
1.9 | 1.9 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.9 | 3.9 | GO:0060596 | mammary placode formation(GO:0060596) |
1.9 | 19.3 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
1.9 | 3.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.9 | 17.3 | GO:0000305 | response to oxygen radical(GO:0000305) |
1.9 | 1.9 | GO:0031860 | telomeric loop formation(GO:0031627) telomeric 3' overhang formation(GO:0031860) |
1.9 | 13.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.9 | 3.8 | GO:1902268 | polyamine transport(GO:0015846) negative regulation of polyamine transmembrane transport(GO:1902268) |
1.9 | 1.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.9 | 17.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
1.9 | 7.6 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
1.9 | 20.9 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
1.9 | 3.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
1.9 | 62.6 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
1.9 | 5.7 | GO:0000012 | single strand break repair(GO:0000012) |
1.9 | 1.9 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
1.9 | 3.8 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.9 | 11.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
1.9 | 3.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.9 | 1.9 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.9 | 7.5 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
1.9 | 1.9 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
1.9 | 3.8 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
1.9 | 11.3 | GO:0051304 | chromosome separation(GO:0051304) |
1.9 | 13.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.9 | 3.8 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
1.9 | 35.7 | GO:0000266 | mitochondrial fission(GO:0000266) |
1.9 | 11.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
1.9 | 3.8 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
1.9 | 11.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.9 | 3.7 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
1.9 | 1.9 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.9 | 70.7 | GO:0030168 | platelet activation(GO:0030168) |
1.9 | 1.9 | GO:0015817 | histidine transport(GO:0015817) |
1.9 | 5.6 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
1.9 | 16.7 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
1.9 | 1.9 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
1.8 | 5.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.8 | 1.8 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.8 | 9.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.8 | 12.9 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
1.8 | 7.3 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
1.8 | 11.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
1.8 | 7.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.8 | 1.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.8 | 5.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.8 | 9.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
1.8 | 5.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.8 | 16.2 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
1.8 | 1.8 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.8 | 35.9 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
1.8 | 3.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.8 | 8.9 | GO:0031297 | replication fork processing(GO:0031297) |
1.8 | 1.8 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
1.8 | 1.8 | GO:0061450 | trophoblast cell migration(GO:0061450) |
1.8 | 1.8 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
1.8 | 7.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.8 | 19.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.7 | 3.5 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
1.7 | 1.7 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.7 | 7.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
1.7 | 10.4 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
1.7 | 1.7 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.7 | 25.9 | GO:0006414 | translational elongation(GO:0006414) |
1.7 | 5.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.7 | 8.6 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
1.7 | 3.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.7 | 5.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
1.7 | 3.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
1.7 | 3.4 | GO:0015819 | lysine transport(GO:0015819) |
1.7 | 13.7 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
1.7 | 3.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.7 | 10.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.7 | 1.7 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
1.7 | 1.7 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
1.7 | 3.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.7 | 3.4 | GO:0060056 | mammary gland involution(GO:0060056) |
1.7 | 22.0 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
1.7 | 3.4 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
1.7 | 5.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.7 | 3.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
1.7 | 6.7 | GO:0034505 | tooth mineralization(GO:0034505) |
1.7 | 1.7 | GO:0070384 | Harderian gland development(GO:0070384) |
1.7 | 1.7 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.7 | 3.4 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
1.7 | 3.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.7 | 21.8 | GO:0030488 | tRNA methylation(GO:0030488) |
1.7 | 10.0 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
1.7 | 1.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.7 | 1.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
1.7 | 3.3 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
1.7 | 1.7 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
1.7 | 1.7 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
1.7 | 3.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.7 | 3.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.7 | 1.7 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.7 | 6.6 | GO:0036233 | glycine import(GO:0036233) |
1.7 | 9.9 | GO:0009299 | mRNA transcription(GO:0009299) |
1.7 | 5.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
1.6 | 61.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
1.6 | 11.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.6 | 8.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.6 | 4.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
1.6 | 8.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.6 | 11.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
1.6 | 1.6 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
1.6 | 1.6 | GO:0030242 | pexophagy(GO:0030242) |
1.6 | 8.2 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
1.6 | 1.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
1.6 | 1.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
1.6 | 3.3 | GO:0043144 | snoRNA processing(GO:0043144) |
1.6 | 9.8 | GO:0051657 | maintenance of organelle location(GO:0051657) |
1.6 | 9.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.6 | 4.9 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
1.6 | 8.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
1.6 | 8.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
1.6 | 9.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.6 | 1.6 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
1.6 | 3.2 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
1.6 | 1.6 | GO:0015808 | L-alanine transport(GO:0015808) |
1.6 | 6.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
1.6 | 11.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
1.6 | 14.4 | GO:0016926 | protein desumoylation(GO:0016926) |
1.6 | 6.4 | GO:0016574 | histone ubiquitination(GO:0016574) |
1.6 | 1.6 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.6 | 1.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
1.6 | 7.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
1.6 | 3.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
1.6 | 6.3 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
1.6 | 3.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.6 | 1.6 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
1.6 | 7.9 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) positive regulation of brown fat cell differentiation(GO:0090336) |
1.6 | 12.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
1.6 | 1.6 | GO:0042637 | catagen(GO:0042637) |
1.6 | 9.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.6 | 1.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.6 | 3.1 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
1.6 | 3.1 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
1.5 | 57.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
1.5 | 6.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.5 | 1.5 | GO:0044838 | cell quiescence(GO:0044838) |
1.5 | 7.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.5 | 3.1 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.5 | 4.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.5 | 16.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.5 | 3.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
1.5 | 3.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.5 | 3.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
1.5 | 6.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
1.5 | 10.7 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
1.5 | 3.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
1.5 | 6.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
1.5 | 1.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.5 | 3.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
1.5 | 3.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
1.5 | 9.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
1.5 | 1.5 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
1.5 | 1.5 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
1.5 | 3.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.5 | 3.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.5 | 3.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
1.5 | 6.0 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
1.5 | 1.5 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
1.5 | 36.0 | GO:0051865 | protein autoubiquitination(GO:0051865) |
1.5 | 12.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.5 | 6.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
1.5 | 3.0 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
1.5 | 20.8 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
1.5 | 1.5 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
1.5 | 4.5 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.5 | 1.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.5 | 4.4 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) negative regulation of sprouting angiogenesis(GO:1903671) |
1.5 | 1.5 | GO:0051409 | response to nitrosative stress(GO:0051409) |
1.5 | 3.0 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
1.5 | 3.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.5 | 8.9 | GO:0050892 | intestinal absorption(GO:0050892) |
1.5 | 1.5 | GO:0060214 | endocardium formation(GO:0060214) |
1.5 | 1.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.5 | 5.9 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
1.5 | 1.5 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
1.5 | 1.5 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
1.5 | 26.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
1.5 | 4.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
1.5 | 8.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
1.5 | 2.9 | GO:0031034 | myosin filament assembly(GO:0031034) |
1.5 | 7.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
1.5 | 31.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
1.5 | 4.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
1.4 | 4.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
1.4 | 2.9 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.4 | 43.2 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
1.4 | 1.4 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
1.4 | 2.9 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
1.4 | 21.4 | GO:0017144 | drug metabolic process(GO:0017144) |
1.4 | 2.9 | GO:0048242 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
1.4 | 4.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
1.4 | 10.0 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
1.4 | 7.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
1.4 | 2.8 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.4 | 4.3 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
1.4 | 4.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.4 | 7.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.4 | 2.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.4 | 8.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
1.4 | 4.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
1.4 | 45.1 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
1.4 | 5.6 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
1.4 | 7.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
1.4 | 12.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.4 | 1.4 | GO:0060416 | response to growth hormone(GO:0060416) |
1.4 | 2.8 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
1.4 | 20.9 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
1.4 | 30.7 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
1.4 | 2.8 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
1.4 | 1.4 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
1.4 | 1.4 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.4 | 2.8 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
1.4 | 2.8 | GO:0070831 | basement membrane assembly(GO:0070831) |
1.4 | 1.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.4 | 16.5 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
1.4 | 2.8 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
1.4 | 9.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
1.4 | 1.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
1.4 | 1.4 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
1.4 | 4.1 | GO:0070633 | transepithelial transport(GO:0070633) |
1.4 | 2.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.4 | 1.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.4 | 2.7 | GO:0006071 | glycerol metabolic process(GO:0006071) |
1.4 | 12.2 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
1.3 | 2.7 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
1.3 | 1.3 | GO:0007567 | parturition(GO:0007567) |
1.3 | 2.7 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
1.3 | 1.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
1.3 | 2.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.3 | 4.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.3 | 12.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
1.3 | 26.7 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
1.3 | 12.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.3 | 20.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
1.3 | 2.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
1.3 | 4.0 | GO:0035994 | response to muscle stretch(GO:0035994) |
1.3 | 103.6 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
1.3 | 4.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
1.3 | 2.6 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.3 | 1.3 | GO:0018377 | protein myristoylation(GO:0018377) |
1.3 | 14.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
1.3 | 13.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
1.3 | 30.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
1.3 | 14.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
1.3 | 1.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.3 | 1.3 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.3 | 2.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
1.3 | 1.3 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
1.3 | 1.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
1.3 | 2.6 | GO:0006907 | pinocytosis(GO:0006907) |
1.3 | 1.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
1.3 | 13.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
1.3 | 1.3 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
1.3 | 6.5 | GO:0007097 | nuclear migration(GO:0007097) |
1.3 | 2.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.3 | 5.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.3 | 21.9 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
1.3 | 3.9 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
1.3 | 6.4 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
1.3 | 1.3 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
1.3 | 1.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
1.3 | 1.3 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
1.3 | 2.6 | GO:0050832 | defense response to fungus(GO:0050832) |
1.3 | 2.5 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.3 | 10.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.3 | 10.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
1.3 | 1.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.3 | 2.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.3 | 1.3 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
1.3 | 1.3 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
1.3 | 12.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
1.3 | 1.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.3 | 76.3 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
1.3 | 2.5 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
1.2 | 1.2 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.2 | 1.2 | GO:0051904 | pigment granule transport(GO:0051904) |
1.2 | 2.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.2 | 1.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
1.2 | 1.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
1.2 | 12.4 | GO:0010737 | protein kinase A signaling(GO:0010737) |
1.2 | 12.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
1.2 | 1.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.2 | 18.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.2 | 3.7 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
1.2 | 2.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
1.2 | 3.7 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.2 | 2.5 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
1.2 | 2.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.2 | 7.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
1.2 | 3.7 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
1.2 | 20.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
1.2 | 6.1 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
1.2 | 15.8 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) |
1.2 | 2.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.2 | 8.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.2 | 6.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.2 | 6.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.2 | 3.6 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
1.2 | 10.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.2 | 4.8 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
1.2 | 9.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.2 | 1.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
1.2 | 8.4 | GO:0006734 | NADH metabolic process(GO:0006734) |
1.2 | 3.6 | GO:0051953 | negative regulation of amine transport(GO:0051953) |
1.2 | 2.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.2 | 2.4 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
1.2 | 1.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
1.2 | 2.4 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
1.2 | 3.6 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
1.2 | 1.2 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
1.2 | 1.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.2 | 9.5 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
1.2 | 2.4 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
1.2 | 1.2 | GO:0015791 | polyol transport(GO:0015791) |
1.2 | 1.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.2 | 4.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.2 | 1.2 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.2 | 5.9 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
1.2 | 2.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.2 | 1.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.2 | 3.5 | GO:0007031 | peroxisome organization(GO:0007031) |
1.2 | 8.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.2 | 1.2 | GO:0014002 | astrocyte development(GO:0014002) |
1.2 | 2.3 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
1.2 | 2.3 | GO:0050810 | regulation of steroid biosynthetic process(GO:0050810) |
1.2 | 3.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.2 | 1.2 | GO:0002337 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
1.2 | 49.7 | GO:0051607 | defense response to virus(GO:0051607) |
1.1 | 2.3 | GO:0014061 | regulation of norepinephrine secretion(GO:0014061) norepinephrine secretion(GO:0048243) |
1.1 | 6.9 | GO:0034063 | stress granule assembly(GO:0034063) |
1.1 | 5.7 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.1 | 13.7 | GO:0006953 | acute-phase response(GO:0006953) |
1.1 | 3.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
1.1 | 3.4 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
1.1 | 2.3 | GO:0015889 | cobalamin transport(GO:0015889) |
1.1 | 2.3 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
1.1 | 11.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
1.1 | 2.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
1.1 | 2.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
1.1 | 2.3 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.1 | 1.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
1.1 | 16.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
1.1 | 3.4 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
1.1 | 1.1 | GO:0045472 | response to ether(GO:0045472) |
1.1 | 1.1 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
1.1 | 3.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.1 | 1.1 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
1.1 | 4.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.1 | 3.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.1 | 7.7 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.1 | 4.4 | GO:0080111 | DNA demethylation(GO:0080111) |
1.1 | 2.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
1.1 | 8.8 | GO:0044804 | nucleophagy(GO:0044804) |
1.1 | 1.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.1 | 12.1 | GO:1990266 | neutrophil migration(GO:1990266) |
1.1 | 6.6 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.1 | 1.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.1 | 4.4 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
1.1 | 2.2 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
1.1 | 15.3 | GO:0009411 | response to UV(GO:0009411) |
1.1 | 1.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.1 | 1.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.1 | 2.2 | GO:0048102 | autophagic cell death(GO:0048102) |
1.1 | 1.1 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
1.1 | 3.2 | GO:0046688 | response to copper ion(GO:0046688) |
1.1 | 1.1 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
1.1 | 7.5 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
1.1 | 1.1 | GO:0050955 | thermoception(GO:0050955) |
1.1 | 2.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.1 | 1.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
1.1 | 13.8 | GO:0016925 | protein sumoylation(GO:0016925) |
1.1 | 3.2 | GO:0043987 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
1.1 | 6.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
1.1 | 9.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
1.1 | 3.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.1 | 1.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.1 | 2.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.1 | 3.2 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
1.1 | 5.3 | GO:0010165 | response to X-ray(GO:0010165) |
1.0 | 1.0 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
1.0 | 4.2 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
1.0 | 1.0 | GO:0035973 | aggrephagy(GO:0035973) |
1.0 | 6.2 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
1.0 | 31.9 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
1.0 | 4.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) positive regulation of establishment of protein localization to telomere(GO:1904851) |
1.0 | 5.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
1.0 | 1.0 | GO:0071374 | response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
1.0 | 3.0 | GO:0034508 | centromere complex assembly(GO:0034508) |
1.0 | 2.0 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
1.0 | 8.1 | GO:0001706 | endoderm formation(GO:0001706) |
1.0 | 2.0 | GO:1904358 | positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
1.0 | 5.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) protein localization to lysosome(GO:0061462) |
1.0 | 1.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
1.0 | 2.0 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
1.0 | 1.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
1.0 | 22.9 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
1.0 | 2.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.0 | 8.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.0 | 3.0 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
1.0 | 1.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.0 | 3.9 | GO:0016572 | histone phosphorylation(GO:0016572) |
1.0 | 1.0 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.0 | 2.9 | GO:0006265 | DNA topological change(GO:0006265) |
1.0 | 1.9 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
1.0 | 1.9 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.0 | 1.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.0 | 1.0 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.0 | 9.6 | GO:0043627 | response to estrogen(GO:0043627) |
1.0 | 1.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.0 | 6.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.9 | 2.8 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.9 | 2.8 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.9 | 3.8 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.9 | 21.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.9 | 16.9 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.9 | 2.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.9 | 1.9 | GO:0070266 | necroptotic process(GO:0070266) |
0.9 | 0.9 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.9 | 6.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.9 | 10.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.9 | 2.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.9 | 8.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.9 | 10.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.9 | 0.9 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.9 | 2.8 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.9 | 11.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.9 | 1.8 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.9 | 7.3 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.9 | 2.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.9 | 4.5 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.9 | 1.8 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.9 | 0.9 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.9 | 8.1 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.9 | 26.0 | GO:0051168 | nuclear export(GO:0051168) |
0.9 | 17.0 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.9 | 28.5 | GO:0006397 | mRNA processing(GO:0006397) |
0.9 | 1.8 | GO:0001840 | neural plate development(GO:0001840) |
0.9 | 8.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.9 | 8.9 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.9 | 0.9 | GO:0009124 | nucleoside monophosphate biosynthetic process(GO:0009124) |
0.9 | 8.8 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.9 | 1.8 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.9 | 14.9 | GO:0031960 | response to corticosteroid(GO:0031960) |
0.9 | 5.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.9 | 5.2 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.9 | 1.7 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.9 | 0.9 | GO:0009451 | RNA modification(GO:0009451) |
0.9 | 2.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.9 | 1.7 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.8 | 0.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.8 | 1.7 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.8 | 10.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.8 | 0.8 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.8 | 0.8 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.8 | 1.7 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.8 | 4.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.8 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
0.8 | 7.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.8 | 3.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.8 | 1.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.8 | 1.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.8 | 17.0 | GO:0035036 | cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
0.8 | 2.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.8 | 1.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.8 | 0.8 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.8 | 2.4 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.8 | 7.2 | GO:0035094 | response to nicotine(GO:0035094) |
0.8 | 2.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.8 | 26.5 | GO:0006310 | DNA recombination(GO:0006310) |
0.8 | 0.8 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.8 | 2.4 | GO:0042044 | fluid transport(GO:0042044) |
0.8 | 2.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.8 | 1.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.8 | 7.9 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.8 | 4.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.8 | 0.8 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.8 | 2.4 | GO:0033198 | response to ATP(GO:0033198) |
0.8 | 9.4 | GO:0001825 | blastocyst formation(GO:0001825) |
0.8 | 0.8 | GO:0015747 | urate transport(GO:0015747) |
0.8 | 0.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 1.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.8 | 0.8 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.8 | 1.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.8 | 4.7 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.8 | 3.9 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.8 | 1.6 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
0.8 | 2.3 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.8 | 3.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.8 | 0.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.8 | 7.6 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.8 | 0.8 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.8 | 1.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.8 | 1.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.8 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.7 | 1.5 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.7 | 1.5 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.7 | 2.2 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.7 | 3.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.7 | 6.0 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.7 | 3.7 | GO:0048599 | oocyte development(GO:0048599) |
0.7 | 1.5 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.7 | 4.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.7 | 1.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.7 | 13.1 | GO:0007569 | cell aging(GO:0007569) |
0.7 | 4.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.7 | 2.2 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.7 | 3.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.7 | 0.7 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.7 | 2.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.7 | 6.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.7 | 0.7 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.7 | 1.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.7 | 1.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.7 | 0.7 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.7 | 0.7 | GO:0030578 | PML body organization(GO:0030578) |
0.7 | 0.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.7 | 2.9 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.7 | 1.4 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.7 | 2.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.7 | 1.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 12.0 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
0.7 | 0.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) paranodal junction assembly(GO:0030913) |
0.7 | 0.7 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.7 | 1.4 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.7 | 18.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.7 | 1.4 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.7 | 1.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.7 | 2.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.7 | 0.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.7 | 1.4 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.7 | 2.1 | GO:0045056 | transcytosis(GO:0045056) |
0.7 | 0.7 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.7 | 0.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.7 | 1.4 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.7 | 0.7 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
0.7 | 1.4 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.7 | 3.4 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.7 | 3.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.7 | 7.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.7 | 10.8 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.7 | 122.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.7 | 3.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.7 | 0.7 | GO:0021564 | vagus nerve development(GO:0021564) |
0.7 | 0.7 | GO:0043383 | negative T cell selection(GO:0043383) |
0.7 | 0.7 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.7 | 1.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.7 | 5.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.7 | 7.9 | GO:0043241 | protein complex disassembly(GO:0043241) |
0.7 | 1.3 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.7 | 25.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.7 | 7.9 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.7 | 3.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.7 | 6.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.7 | 1.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.7 | 5.2 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.6 | 15.5 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.6 | 1.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.6 | 2.6 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.6 | 1.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.6 | 0.6 | GO:0010518 | positive regulation of phospholipase activity(GO:0010518) |
0.6 | 21.0 | GO:0050817 | coagulation(GO:0050817) |
0.6 | 1.3 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.6 | 0.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.6 | 1.3 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.6 | 35.0 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.6 | 0.6 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.6 | 1.2 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.6 | 16.1 | GO:0051297 | centrosome organization(GO:0051297) |
0.6 | 0.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.6 | 0.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.6 | 1.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.6 | 0.6 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 63.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.6 | 7.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.6 | 8.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.6 | 0.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.6 | 1.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.6 | 17.3 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.6 | 5.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.6 | 5.3 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.6 | 0.6 | GO:0002889 | regulation of B cell mediated immunity(GO:0002712) regulation of immunoglobulin mediated immune response(GO:0002889) |
0.6 | 0.6 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.6 | 1.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.6 | 1.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.6 | 0.6 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.6 | 12.4 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.6 | 1.2 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
0.6 | 0.6 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.6 | 1.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.6 | 1.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.6 | 2.8 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.6 | 0.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.6 | 13.1 | GO:0009408 | response to heat(GO:0009408) |
0.6 | 1.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.6 | 1.7 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.6 | 1.1 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.6 | 1.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.6 | 14.4 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.6 | 0.6 | GO:2000407 | regulation of T cell extravasation(GO:2000407) |
0.5 | 6.6 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.5 | 0.5 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.5 | 1.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.5 | 5.4 | GO:0016575 | histone deacetylation(GO:0016575) |
0.5 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.5 | 9.7 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.5 | 10.8 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.5 | 0.5 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.5 | 31.8 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.5 | 1.1 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
0.5 | 1.6 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.5 | 0.5 | GO:0010712 | regulation of collagen metabolic process(GO:0010712) |
0.5 | 1.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.5 | 2.7 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.5 | 0.5 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.5 | 2.6 | GO:0019915 | lipid storage(GO:0019915) |
0.5 | 2.6 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.5 | 5.7 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.5 | 1.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.5 | 0.5 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.5 | 0.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.5 | 1.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.5 | 1.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.5 | 13.6 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.5 | 2.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.5 | 3.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.5 | 0.5 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.5 | 0.5 | GO:0070231 | T cell apoptotic process(GO:0070231) |
0.5 | 1.0 | GO:0070268 | cornification(GO:0070268) |
0.5 | 1.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.5 | 1.9 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
0.5 | 1.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.5 | 0.5 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.5 | 8.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.5 | 0.9 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.5 | 39.6 | GO:0032259 | methylation(GO:0032259) |
0.5 | 27.0 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.5 | 7.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.5 | 0.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.5 | 4.6 | GO:0042246 | tissue regeneration(GO:0042246) |
0.5 | 0.5 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.5 | 37.6 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.5 | 1.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 1.8 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.4 | 0.4 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.4 | 0.9 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.4 | 5.3 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.4 | 1.8 | GO:0031638 | zymogen activation(GO:0031638) |
0.4 | 0.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.4 | 1.3 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.4 | 0.4 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.4 | 0.9 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 0.4 | GO:0032400 | melanosome localization(GO:0032400) pigment granule localization(GO:0051875) |
0.4 | 0.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.4 | 0.8 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.4 | 0.4 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.4 | 0.4 | GO:0019081 | viral translation(GO:0019081) |
0.4 | 0.8 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.4 | 1.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 4.0 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.4 | 16.9 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.4 | 0.4 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.4 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 2.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.4 | 1.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.4 | 1.9 | GO:0000338 | protein deneddylation(GO:0000338) |
0.4 | 12.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.4 | 3.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.4 | 17.3 | GO:0006457 | protein folding(GO:0006457) |
0.4 | 2.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.4 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 6.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.4 | 2.7 | GO:0007492 | endoderm development(GO:0007492) |
0.4 | 0.8 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.4 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 0.4 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.4 | 0.7 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.4 | 0.7 | GO:0061515 | myeloid cell development(GO:0061515) |
0.4 | 0.4 | GO:0033058 | directional locomotion(GO:0033058) |
0.4 | 0.4 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.4 | 0.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.3 | 0.3 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 0.3 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) positive regulation of neurotransmitter uptake(GO:0051582) dopamine uptake involved in synaptic transmission(GO:0051583) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) catecholamine uptake involved in synaptic transmission(GO:0051934) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.3 | 1.7 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.3 | 0.3 | GO:0043471 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.3 | 23.3 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.3 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 1.7 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.3 | 23.6 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.3 | 1.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 2.6 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.3 | 2.0 | GO:0006342 | chromatin silencing(GO:0006342) |
0.3 | 0.3 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.3 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.3 | 23.5 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.3 | 3.8 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.3 | 1.9 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.3 | 37.2 | GO:0048232 | male gamete generation(GO:0048232) |
0.3 | 1.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.3 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 3.4 | GO:0031279 | regulation of cyclase activity(GO:0031279) |
0.3 | 0.3 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) nephrogenic mesenchyme development(GO:0072076) |
0.3 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 2.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.3 | 3.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.3 | 0.3 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.3 | 0.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 24.8 | GO:0006814 | sodium ion transport(GO:0006814) |
0.3 | 1.5 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.3 | 0.3 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.3 | 0.3 | GO:0009624 | response to nematode(GO:0009624) |
0.3 | 1.1 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.3 | 0.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.3 | 4.7 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.3 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 2.2 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.3 | 0.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.3 | 0.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.3 | 0.3 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) |
0.3 | 0.3 | GO:0071025 | RNA surveillance(GO:0071025) |
0.3 | 0.8 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.3 | 6.8 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.3 | 0.5 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.3 | 3.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 0.8 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 0.3 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.3 | 1.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.3 | 0.5 | GO:0048631 | skeletal muscle tissue growth(GO:0048630) regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 0.3 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 274.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.2 | 1.2 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.2 | 1.5 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.2 | 1.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 1.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.2 | 0.2 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.2 | 4.7 | GO:0042060 | wound healing(GO:0042060) |
0.2 | 0.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 1.8 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 1.1 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.2 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.2 | 9.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 0.2 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.2 | 1.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 0.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 0.9 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 0.2 | GO:0002118 | aggressive behavior(GO:0002118) positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.2 | 0.2 | GO:0070227 | lymphocyte apoptotic process(GO:0070227) |
0.2 | 0.2 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.2 | 2.1 | GO:0006959 | humoral immune response(GO:0006959) |
0.2 | 0.4 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.2 | 0.4 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 0.8 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.2 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.2 | 1.0 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.2 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.2 | 1.7 | GO:2001056 | positive regulation of cysteine-type endopeptidase activity(GO:2001056) |
0.2 | 0.4 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.2 | 0.9 | GO:0090382 | phagosome maturation(GO:0090382) |
0.2 | 0.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 30.7 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.2 | 1.0 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 1.5 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.2 | 0.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.2 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.8 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
0.2 | 0.3 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 2.7 | GO:0006396 | RNA processing(GO:0006396) |
0.1 | 0.1 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.3 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.1 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.1 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.4 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.8 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 0.6 | GO:0001947 | heart looping(GO:0001947) |
0.1 | 0.2 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 1.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 2.0 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.3 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.4 | GO:0014015 | positive regulation of gliogenesis(GO:0014015) |
0.1 | 0.3 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.1 | 0.3 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.1 | 0.3 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.1 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 0.6 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.1 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 1.0 | GO:0060402 | calcium ion transport into cytosol(GO:0060402) |
0.1 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.5 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.3 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.1 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.1 | GO:0071216 | cellular response to biotic stimulus(GO:0071216) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 0.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.1 | GO:1903578 | regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
0.1 | 0.1 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.1 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 2.3 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) |
0.0 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 4.9 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 1.0 | GO:0042384 | cilium assembly(GO:0042384) |
0.0 | 0.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:1900409 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of response to oxidative stress(GO:1902884) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
30.3 | 151.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
19.5 | 77.9 | GO:1990130 | Iml1 complex(GO:1990130) |
17.2 | 51.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
14.7 | 44.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
12.9 | 38.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
12.5 | 62.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
11.5 | 23.1 | GO:0089701 | U2AF(GO:0089701) |
11.2 | 45.0 | GO:0097450 | astrocyte end-foot(GO:0097450) |
11.2 | 67.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
11.1 | 88.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
10.9 | 10.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
10.7 | 64.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
9.6 | 28.7 | GO:0005745 | m-AAA complex(GO:0005745) |
9.5 | 28.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
9.4 | 47.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
9.2 | 101.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
8.9 | 26.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
8.9 | 26.6 | GO:0044393 | microspike(GO:0044393) |
8.4 | 50.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
8.3 | 33.2 | GO:0033269 | internode region of axon(GO:0033269) |
8.2 | 197.0 | GO:0097228 | sperm principal piece(GO:0097228) |
8.0 | 16.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
7.8 | 70.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
7.7 | 54.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
7.7 | 7.7 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
7.2 | 21.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
7.1 | 56.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
7.1 | 21.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
7.1 | 28.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
7.1 | 21.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
7.0 | 28.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
6.8 | 102.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
6.8 | 20.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
6.7 | 26.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
6.6 | 19.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
6.6 | 65.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
6.5 | 52.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
6.5 | 32.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
6.4 | 44.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
6.4 | 44.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
6.4 | 6.4 | GO:1902555 | endoribonuclease complex(GO:1902555) |
6.2 | 43.7 | GO:0031931 | TORC1 complex(GO:0031931) |
6.1 | 24.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
6.0 | 6.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
5.7 | 62.5 | GO:0031143 | pseudopodium(GO:0031143) |
5.7 | 17.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
5.7 | 17.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
5.7 | 17.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
5.5 | 16.6 | GO:0042827 | platelet dense granule(GO:0042827) |
5.5 | 33.1 | GO:0045179 | apical cortex(GO:0045179) |
5.4 | 43.5 | GO:0043203 | axon hillock(GO:0043203) |
5.4 | 16.3 | GO:0005914 | spot adherens junction(GO:0005914) |
5.3 | 64.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
5.3 | 42.3 | GO:0016600 | flotillin complex(GO:0016600) |
5.3 | 10.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
5.3 | 10.5 | GO:0031523 | Myb complex(GO:0031523) |
5.3 | 21.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
5.2 | 36.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
5.2 | 36.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
5.2 | 31.0 | GO:0071986 | Ragulator complex(GO:0071986) |
5.1 | 20.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
5.1 | 45.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
5.1 | 5.1 | GO:1990745 | EARP complex(GO:1990745) |
5.1 | 60.8 | GO:0031528 | microvillus membrane(GO:0031528) |
5.1 | 20.2 | GO:0070545 | PeBoW complex(GO:0070545) |
5.0 | 20.0 | GO:0044194 | cytolytic granule(GO:0044194) |
5.0 | 20.0 | GO:0000938 | GARP complex(GO:0000938) |
5.0 | 79.6 | GO:0000145 | exocyst(GO:0000145) |
5.0 | 39.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
4.9 | 14.8 | GO:0016939 | kinesin II complex(GO:0016939) |
4.9 | 9.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
4.9 | 14.8 | GO:0032437 | cuticular plate(GO:0032437) |
4.9 | 78.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
4.8 | 28.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
4.8 | 19.3 | GO:0035339 | SPOTS complex(GO:0035339) |
4.8 | 19.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
4.7 | 4.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
4.7 | 318.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
4.7 | 32.6 | GO:0071546 | pi-body(GO:0071546) |
4.6 | 23.1 | GO:0005638 | lamin filament(GO:0005638) |
4.6 | 13.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
4.6 | 41.4 | GO:0005869 | dynactin complex(GO:0005869) |
4.6 | 59.7 | GO:0001891 | phagocytic cup(GO:0001891) |
4.6 | 45.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
4.6 | 4.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
4.6 | 18.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
4.6 | 41.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
4.5 | 4.5 | GO:1990423 | RZZ complex(GO:1990423) |
4.5 | 40.4 | GO:0016363 | nuclear matrix(GO:0016363) |
4.5 | 188.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
4.5 | 17.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
4.4 | 13.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
4.4 | 4.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
4.4 | 13.2 | GO:0097413 | Lewy body(GO:0097413) |
4.4 | 17.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
4.4 | 26.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
4.4 | 26.1 | GO:0031415 | NatA complex(GO:0031415) |
4.3 | 34.5 | GO:0042581 | specific granule(GO:0042581) |
4.2 | 46.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
4.2 | 21.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
4.2 | 41.8 | GO:0031968 | organelle outer membrane(GO:0031968) |
4.2 | 25.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
4.1 | 45.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
4.1 | 61.4 | GO:0097440 | apical dendrite(GO:0097440) |
4.1 | 12.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
4.1 | 12.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
4.0 | 4.0 | GO:0016460 | myosin II complex(GO:0016460) |
4.0 | 31.8 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
3.9 | 31.5 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
3.9 | 63.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
3.9 | 11.8 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
3.9 | 3.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
3.9 | 11.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
3.9 | 19.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
3.9 | 19.4 | GO:0097422 | tubular endosome(GO:0097422) |
3.8 | 19.2 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
3.8 | 11.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
3.8 | 7.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
3.8 | 37.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
3.8 | 30.2 | GO:0034464 | BBSome(GO:0034464) |
3.8 | 3.8 | GO:0045177 | apical part of cell(GO:0045177) |
3.7 | 30.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
3.7 | 15.0 | GO:0005642 | annulate lamellae(GO:0005642) |
3.7 | 29.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
3.7 | 26.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
3.7 | 59.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
3.7 | 74.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
3.7 | 33.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
3.7 | 7.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
3.7 | 21.9 | GO:0032009 | early phagosome(GO:0032009) |
3.6 | 76.6 | GO:0031941 | filamentous actin(GO:0031941) |
3.6 | 18.2 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
3.6 | 21.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
3.6 | 21.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
3.6 | 18.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
3.6 | 18.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
3.6 | 78.7 | GO:0090544 | BAF-type complex(GO:0090544) |
3.5 | 208.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
3.5 | 21.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
3.5 | 3.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
3.5 | 20.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
3.5 | 17.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
3.5 | 3.5 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
3.5 | 10.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
3.5 | 6.9 | GO:0002139 | stereocilia coupling link(GO:0002139) |
3.5 | 69.1 | GO:0034451 | centriolar satellite(GO:0034451) |
3.4 | 24.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
3.4 | 150.6 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
3.4 | 27.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
3.4 | 144.9 | GO:0031985 | Golgi cisterna(GO:0031985) |
3.3 | 10.0 | GO:0097443 | sorting endosome(GO:0097443) |
3.3 | 29.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
3.3 | 13.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
3.3 | 16.3 | GO:0061702 | inflammasome complex(GO:0061702) |
3.3 | 3.3 | GO:1904949 | ATPase complex(GO:1904949) |
3.2 | 22.7 | GO:0005916 | fascia adherens(GO:0005916) |
3.2 | 132.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
3.2 | 6.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
3.2 | 9.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
3.2 | 51.6 | GO:0005795 | Golgi stack(GO:0005795) |
3.2 | 107.8 | GO:0016592 | mediator complex(GO:0016592) |
3.2 | 15.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
3.1 | 12.6 | GO:0097452 | GAIT complex(GO:0097452) |
3.1 | 94.2 | GO:0005776 | autophagosome(GO:0005776) |
3.1 | 50.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
3.1 | 12.5 | GO:0042583 | chromaffin granule(GO:0042583) |
3.1 | 6.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
3.1 | 6.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
3.1 | 24.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
3.1 | 68.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
3.0 | 9.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
3.0 | 33.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
3.0 | 12.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
3.0 | 3.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
3.0 | 15.1 | GO:0005683 | U7 snRNP(GO:0005683) |
3.0 | 15.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
3.0 | 30.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
3.0 | 6.0 | GO:1990923 | PET complex(GO:1990923) |
3.0 | 12.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
3.0 | 35.7 | GO:0030904 | retromer complex(GO:0030904) |
3.0 | 5.9 | GO:0005767 | secondary lysosome(GO:0005767) |
2.9 | 35.4 | GO:0036038 | MKS complex(GO:0036038) |
2.9 | 14.7 | GO:0051286 | cell tip(GO:0051286) |
2.9 | 20.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
2.9 | 37.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
2.9 | 149.6 | GO:0005811 | lipid particle(GO:0005811) |
2.9 | 48.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
2.9 | 11.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
2.9 | 2.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
2.9 | 14.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
2.8 | 2.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
2.8 | 28.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
2.8 | 56.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
2.8 | 346.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
2.8 | 22.5 | GO:0031901 | early endosome membrane(GO:0031901) |
2.8 | 36.6 | GO:0000242 | pericentriolar material(GO:0000242) |
2.8 | 30.9 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
2.8 | 22.5 | GO:0032982 | myosin filament(GO:0032982) |
2.8 | 11.2 | GO:0072687 | meiotic spindle(GO:0072687) |
2.8 | 93.7 | GO:0005938 | cell cortex(GO:0005938) |
2.7 | 24.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
2.7 | 32.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
2.7 | 13.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
2.7 | 8.1 | GO:0071797 | LUBAC complex(GO:0071797) |
2.7 | 16.2 | GO:0005635 | nuclear envelope(GO:0005635) |
2.7 | 105.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
2.7 | 5.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
2.7 | 13.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
2.7 | 8.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.7 | 40.1 | GO:0043205 | fibril(GO:0043205) |
2.7 | 24.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
2.6 | 26.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
2.6 | 21.1 | GO:0005861 | troponin complex(GO:0005861) |
2.6 | 7.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.6 | 5.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.6 | 2.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
2.6 | 5.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
2.6 | 10.5 | GO:0005827 | polar microtubule(GO:0005827) |
2.6 | 20.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
2.6 | 114.7 | GO:0016528 | sarcoplasm(GO:0016528) |
2.6 | 18.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
2.6 | 15.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
2.5 | 7.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
2.5 | 40.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
2.5 | 17.7 | GO:0033263 | CORVET complex(GO:0033263) |
2.5 | 50.0 | GO:0005771 | multivesicular body(GO:0005771) |
2.5 | 10.0 | GO:0030056 | hemidesmosome(GO:0030056) |
2.5 | 7.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
2.5 | 2.5 | GO:0034709 | methylosome(GO:0034709) |
2.5 | 2.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.5 | 19.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
2.5 | 19.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
2.4 | 22.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
2.4 | 9.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
2.4 | 26.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
2.4 | 14.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
2.4 | 4.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.4 | 9.6 | GO:0000796 | condensin complex(GO:0000796) |
2.4 | 2.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
2.4 | 2.4 | GO:0071010 | prespliceosome(GO:0071010) |
2.4 | 11.9 | GO:0043198 | dendritic shaft(GO:0043198) |
2.4 | 16.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
2.3 | 2.3 | GO:0001652 | granular component(GO:0001652) |
2.3 | 25.6 | GO:0044292 | dendrite terminus(GO:0044292) |
2.3 | 30.2 | GO:0033202 | DNA helicase complex(GO:0033202) |
2.3 | 4.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
2.3 | 9.3 | GO:0001650 | fibrillar center(GO:0001650) |
2.3 | 16.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.3 | 6.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.3 | 9.2 | GO:0032433 | filopodium tip(GO:0032433) |
2.3 | 16.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
2.3 | 50.4 | GO:0035861 | site of double-strand break(GO:0035861) |
2.3 | 20.6 | GO:0015629 | actin cytoskeleton(GO:0015629) |
2.3 | 4.6 | GO:0043219 | lateral loop(GO:0043219) |
2.3 | 105.0 | GO:0042641 | actomyosin(GO:0042641) |
2.3 | 6.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
2.3 | 4.5 | GO:0071439 | clathrin complex(GO:0071439) |
2.3 | 4.5 | GO:0036157 | outer dynein arm(GO:0036157) |
2.3 | 2.3 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) spliceosomal snRNP complex(GO:0097525) |
2.3 | 18.1 | GO:0042587 | glycogen granule(GO:0042587) |
2.3 | 15.8 | GO:0042382 | paraspeckles(GO:0042382) |
2.2 | 20.2 | GO:0000124 | SAGA complex(GO:0000124) |
2.2 | 9.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
2.2 | 76.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
2.2 | 20.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
2.2 | 6.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.2 | 17.7 | GO:0032587 | ruffle membrane(GO:0032587) |
2.2 | 52.9 | GO:0015030 | Cajal body(GO:0015030) |
2.2 | 4.4 | GO:0044309 | neuron spine(GO:0044309) |
2.2 | 99.0 | GO:0005901 | caveola(GO:0005901) |
2.2 | 52.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
2.2 | 15.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
2.2 | 6.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
2.2 | 4.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
2.2 | 6.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
2.2 | 2.2 | GO:0030870 | Mre11 complex(GO:0030870) |
2.1 | 12.9 | GO:0032797 | SMN complex(GO:0032797) |
2.1 | 2.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
2.1 | 10.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
2.1 | 12.8 | GO:0031512 | motile primary cilium(GO:0031512) |
2.1 | 6.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
2.1 | 6.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.1 | 21.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
2.1 | 6.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
2.1 | 12.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
2.1 | 23.0 | GO:0000786 | nucleosome(GO:0000786) |
2.1 | 6.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
2.1 | 27.1 | GO:0001772 | immunological synapse(GO:0001772) |
2.1 | 8.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
2.1 | 20.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
2.1 | 37.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
2.1 | 18.7 | GO:0034704 | calcium channel complex(GO:0034704) |
2.1 | 22.6 | GO:0002102 | podosome(GO:0002102) |
2.1 | 94.4 | GO:0016605 | PML body(GO:0016605) |
2.0 | 14.3 | GO:0046930 | pore complex(GO:0046930) |
2.0 | 8.2 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
2.0 | 12.2 | GO:0010369 | chromocenter(GO:0010369) |
2.0 | 303.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
2.0 | 2.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
2.0 | 125.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
2.0 | 6.0 | GO:0005955 | calcineurin complex(GO:0005955) |
2.0 | 8.0 | GO:0072487 | MSL complex(GO:0072487) |
2.0 | 12.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
2.0 | 5.9 | GO:0060091 | kinocilium(GO:0060091) |
2.0 | 29.4 | GO:0045120 | pronucleus(GO:0045120) |
2.0 | 41.0 | GO:0012505 | endomembrane system(GO:0012505) |
1.9 | 3.9 | GO:1990462 | omegasome(GO:1990462) |
1.9 | 1.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
1.9 | 104.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
1.9 | 9.7 | GO:0031252 | cell leading edge(GO:0031252) |
1.9 | 1.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.9 | 30.8 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.9 | 1.9 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.9 | 57.4 | GO:0031526 | brush border membrane(GO:0031526) |
1.9 | 23.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.9 | 49.5 | GO:0032420 | stereocilium(GO:0032420) |
1.9 | 3.8 | GO:0000805 | X chromosome(GO:0000805) |
1.9 | 1.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.9 | 5.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.9 | 5.7 | GO:0097255 | R2TP complex(GO:0097255) |
1.9 | 56.7 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
1.9 | 150.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
1.9 | 26.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.9 | 5.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.9 | 1.9 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
1.9 | 3.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.9 | 137.3 | GO:0000793 | condensed chromosome(GO:0000793) |
1.8 | 7.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
1.8 | 9.2 | GO:0044327 | dendritic spine head(GO:0044327) |
1.8 | 99.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
1.8 | 75.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.8 | 7.3 | GO:0000812 | Swr1 complex(GO:0000812) |
1.8 | 3.6 | GO:0016235 | aggresome(GO:0016235) |
1.8 | 65.6 | GO:0005643 | nuclear pore(GO:0005643) |
1.8 | 7.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.8 | 10.7 | GO:0030894 | replisome(GO:0030894) |
1.8 | 17.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.8 | 3.6 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
1.8 | 296.1 | GO:0005925 | focal adhesion(GO:0005925) |
1.8 | 39.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
1.8 | 5.3 | GO:0042627 | chylomicron(GO:0042627) |
1.8 | 7.1 | GO:0042629 | mast cell granule(GO:0042629) |
1.8 | 21.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
1.7 | 1864.3 | GO:0005829 | cytosol(GO:0005829) |
1.7 | 95.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.7 | 5.2 | GO:0090543 | Flemming body(GO:0090543) |
1.7 | 17.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.7 | 6.9 | GO:0000791 | euchromatin(GO:0000791) |
1.7 | 5.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.7 | 6.8 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
1.7 | 6.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.7 | 8.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
1.7 | 1.7 | GO:0097470 | ribbon synapse(GO:0097470) |
1.7 | 6.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
1.7 | 3.4 | GO:0045180 | basal cortex(GO:0045180) |
1.7 | 14.9 | GO:0005685 | U1 snRNP(GO:0005685) |
1.6 | 1.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.6 | 4.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.6 | 1.6 | GO:0005687 | U4 snRNP(GO:0005687) |
1.6 | 19.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
1.6 | 3.3 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
1.6 | 39.1 | GO:0031090 | organelle membrane(GO:0031090) |
1.6 | 3.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
1.6 | 1.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.6 | 8.0 | GO:0005796 | Golgi lumen(GO:0005796) |
1.6 | 1.6 | GO:0005686 | U2 snRNP(GO:0005686) |
1.6 | 1.6 | GO:0005652 | nuclear lamina(GO:0005652) |
1.6 | 4.8 | GO:0070938 | contractile ring(GO:0070938) |
1.6 | 102.9 | GO:0072562 | blood microparticle(GO:0072562) |
1.6 | 6.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
1.6 | 372.3 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
1.6 | 307.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
1.6 | 3.1 | GO:0030689 | Noc complex(GO:0030689) |
1.6 | 12.5 | GO:0070652 | HAUS complex(GO:0070652) |
1.6 | 31.3 | GO:0005844 | polysome(GO:0005844) |
1.5 | 17.0 | GO:0005682 | U5 snRNP(GO:0005682) |
1.5 | 4.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
1.5 | 4.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.5 | 4.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.5 | 12.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.5 | 46.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.5 | 7.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.5 | 14.7 | GO:0031519 | PcG protein complex(GO:0031519) |
1.5 | 44.0 | GO:0000502 | proteasome complex(GO:0000502) |
1.5 | 8.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.5 | 2.9 | GO:0034399 | nuclear periphery(GO:0034399) |
1.4 | 21.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.4 | 7.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.4 | 4.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.4 | 12.7 | GO:0030914 | STAGA complex(GO:0030914) |
1.4 | 22.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.4 | 1.4 | GO:0030880 | RNA polymerase complex(GO:0030880) |
1.4 | 2.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.4 | 1.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.4 | 11.0 | GO:0000346 | transcription export complex(GO:0000346) |
1.4 | 24.6 | GO:0045178 | basal part of cell(GO:0045178) |
1.4 | 1421.6 | GO:0005654 | nucleoplasm(GO:0005654) |
1.3 | 2.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.3 | 8.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.3 | 16.0 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.3 | 12.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.3 | 38.5 | GO:0034707 | chloride channel complex(GO:0034707) |
1.3 | 6.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
1.3 | 15.8 | GO:0016459 | myosin complex(GO:0016459) |
1.3 | 1.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.3 | 2.6 | GO:0005657 | replication fork(GO:0005657) |
1.3 | 2.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.3 | 14.3 | GO:0005876 | spindle microtubule(GO:0005876) |
1.3 | 7.8 | GO:0005874 | microtubule(GO:0005874) |
1.3 | 3.9 | GO:0033270 | paranode region of axon(GO:0033270) |
1.3 | 1.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.2 | 166.3 | GO:0005667 | transcription factor complex(GO:0005667) |
1.2 | 954.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
1.2 | 8.7 | GO:0043196 | varicosity(GO:0043196) |
1.2 | 4.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
1.2 | 1.2 | GO:0044298 | cell body membrane(GO:0044298) |
1.2 | 18.4 | GO:0005903 | brush border(GO:0005903) |
1.2 | 15.8 | GO:0030057 | desmosome(GO:0030057) |
1.2 | 18.0 | GO:0001726 | ruffle(GO:0001726) |
1.2 | 73.4 | GO:0005581 | collagen trimer(GO:0005581) |
1.2 | 29.4 | GO:0012506 | vesicle membrane(GO:0012506) |
1.1 | 5.7 | GO:0001741 | XY body(GO:0001741) |
1.1 | 24.8 | GO:0055037 | recycling endosome(GO:0055037) |
1.1 | 2.2 | GO:0098536 | deuterosome(GO:0098536) |
1.1 | 2.2 | GO:0014704 | intercalated disc(GO:0014704) |
1.1 | 4.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.1 | 46.6 | GO:0000139 | Golgi membrane(GO:0000139) |
1.1 | 69.2 | GO:0000228 | nuclear chromosome(GO:0000228) |
1.1 | 198.7 | GO:0005815 | microtubule organizing center(GO:0005815) |
1.0 | 1.0 | GO:0002177 | manchette(GO:0002177) |
1.0 | 507.0 | GO:0005739 | mitochondrion(GO:0005739) |
1.0 | 38.0 | GO:0005694 | chromosome(GO:0005694) |
1.0 | 8.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.0 | 22.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.0 | 1.0 | GO:0044308 | axonal spine(GO:0044308) |
1.0 | 15.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
1.0 | 33.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
1.0 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.0 | 153.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.9 | 2.8 | GO:0030425 | dendrite(GO:0030425) |
0.9 | 0.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.9 | 2.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.9 | 16.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.9 | 812.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.9 | 37.2 | GO:0043292 | contractile fiber(GO:0043292) |
0.9 | 7.0 | GO:0031982 | vesicle(GO:0031982) |
0.9 | 13.7 | GO:0036126 | sperm flagellum(GO:0036126) |
0.8 | 11.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.8 | 5.0 | GO:0097458 | neuron part(GO:0097458) |
0.8 | 0.8 | GO:0043218 | compact myelin(GO:0043218) |
0.8 | 1.6 | GO:0005840 | ribosome(GO:0005840) |
0.8 | 3.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.7 | 3.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.7 | 2.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.7 | 1530.7 | GO:0005737 | cytoplasm(GO:0005737) |
0.7 | 32.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.6 | 1.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.6 | 10.1 | GO:0045095 | keratin filament(GO:0045095) |
0.6 | 3.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.6 | 737.5 | GO:0005886 | plasma membrane(GO:0005886) |
0.5 | 866.1 | GO:0016020 | membrane(GO:0016020) |
0.5 | 398.2 | GO:0005576 | extracellular region(GO:0005576) |
0.5 | 67.5 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.4 | 1.7 | GO:0044456 | synapse part(GO:0044456) |
0.4 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
0.4 | 356.9 | GO:0005634 | nucleus(GO:0005634) |
0.4 | 1.4 | GO:0030054 | cell junction(GO:0030054) |
0.3 | 0.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.3 | 3.7 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.2 | 29.1 | GO:0005623 | cell(GO:0005623) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
38.4 | 153.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
37.7 | 113.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
29.4 | 117.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
27.5 | 110.1 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
24.3 | 97.2 | GO:0015265 | urea channel activity(GO:0015265) |
22.1 | 66.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
20.4 | 142.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
18.7 | 56.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
17.5 | 52.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
17.3 | 69.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
16.5 | 49.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
14.9 | 119.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
14.7 | 44.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
14.5 | 101.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
13.8 | 27.7 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
13.7 | 54.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
13.0 | 38.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
12.8 | 38.4 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
12.4 | 37.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
12.1 | 12.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
11.9 | 35.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
11.8 | 35.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
11.4 | 34.3 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
11.1 | 33.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
11.1 | 33.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
11.1 | 11.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
10.8 | 54.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
10.7 | 32.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
10.4 | 31.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
10.4 | 62.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
10.4 | 20.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
10.2 | 30.7 | GO:0004064 | arylesterase activity(GO:0004064) |
10.2 | 40.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
10.1 | 60.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
9.8 | 39.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
9.8 | 78.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
9.8 | 58.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
9.6 | 77.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
9.6 | 48.1 | GO:0070061 | fructose binding(GO:0070061) |
9.6 | 9.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
9.5 | 37.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
9.4 | 28.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
9.2 | 73.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
9.0 | 27.1 | GO:0019961 | interferon binding(GO:0019961) |
8.8 | 17.5 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
8.6 | 25.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
8.6 | 51.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
8.6 | 120.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
8.5 | 42.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
8.4 | 58.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
8.3 | 33.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
8.1 | 56.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
8.0 | 48.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
7.9 | 23.7 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
7.8 | 31.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
7.7 | 23.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
7.7 | 53.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
7.7 | 23.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
7.6 | 7.6 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
7.5 | 37.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
7.5 | 179.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
7.5 | 52.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
7.4 | 7.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
7.4 | 59.0 | GO:0043743 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
7.4 | 22.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
7.3 | 51.4 | GO:0018644 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
7.3 | 43.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
7.2 | 65.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
7.1 | 127.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
7.0 | 21.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
7.0 | 35.0 | GO:0043559 | insulin binding(GO:0043559) |
7.0 | 20.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
6.9 | 20.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
6.9 | 55.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
6.9 | 144.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
6.8 | 20.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
6.8 | 20.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
6.8 | 33.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
6.8 | 20.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
6.7 | 33.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
6.6 | 26.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
6.6 | 19.9 | GO:0016801 | adenosylhomocysteinase activity(GO:0004013) hydrolase activity, acting on ether bonds(GO:0016801) trialkylsulfonium hydrolase activity(GO:0016802) |
6.6 | 19.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
6.4 | 25.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
6.4 | 25.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
6.3 | 38.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
6.3 | 25.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
6.3 | 37.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
6.2 | 25.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
6.2 | 56.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
6.2 | 18.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
6.1 | 30.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
6.1 | 24.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
6.0 | 18.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
6.0 | 24.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
6.0 | 36.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
6.0 | 29.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
6.0 | 53.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
5.9 | 29.7 | GO:1990239 | steroid hormone binding(GO:1990239) |
5.9 | 11.8 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
5.9 | 41.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
5.9 | 17.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
5.8 | 58.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
5.8 | 127.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
5.7 | 23.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
5.7 | 17.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
5.7 | 17.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
5.7 | 22.7 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
5.7 | 17.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
5.6 | 22.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
5.6 | 73.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
5.6 | 185.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
5.6 | 11.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
5.6 | 38.9 | GO:0046790 | virion binding(GO:0046790) |
5.5 | 27.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
5.5 | 22.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
5.5 | 33.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
5.5 | 16.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
5.5 | 32.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
5.4 | 21.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
5.4 | 16.2 | GO:0051425 | PTB domain binding(GO:0051425) |
5.3 | 15.8 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
5.2 | 68.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
5.2 | 15.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
5.2 | 10.4 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
5.2 | 15.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
5.1 | 5.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
5.1 | 15.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
5.1 | 35.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
5.1 | 20.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
5.0 | 20.2 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
5.0 | 20.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
5.0 | 14.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
5.0 | 5.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
5.0 | 5.0 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
4.9 | 9.8 | GO:0034618 | arginine binding(GO:0034618) |
4.9 | 19.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
4.9 | 14.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
4.8 | 14.5 | GO:0043199 | sulfate binding(GO:0043199) |
4.8 | 24.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
4.8 | 19.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
4.8 | 14.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
4.8 | 19.2 | GO:0015232 | heme transporter activity(GO:0015232) |
4.8 | 19.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
4.8 | 19.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
4.8 | 42.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
4.8 | 19.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
4.7 | 47.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
4.7 | 19.0 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
4.7 | 18.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
4.7 | 9.4 | GO:0004096 | catalase activity(GO:0004096) |
4.7 | 42.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
4.6 | 23.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
4.6 | 23.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
4.6 | 13.9 | GO:0030172 | troponin C binding(GO:0030172) |
4.6 | 41.5 | GO:0034582 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
4.6 | 13.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
4.6 | 41.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
4.6 | 4.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
4.6 | 13.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
4.5 | 22.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
4.5 | 40.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
4.5 | 13.6 | GO:0031013 | troponin I binding(GO:0031013) |
4.5 | 44.8 | GO:0031996 | thioesterase binding(GO:0031996) |
4.5 | 17.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
4.5 | 13.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
4.4 | 48.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
4.4 | 4.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
4.4 | 39.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
4.4 | 52.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
4.4 | 13.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
4.3 | 21.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
4.3 | 73.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
4.3 | 8.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
4.3 | 8.6 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
4.3 | 34.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
4.3 | 4.3 | GO:0031014 | troponin T binding(GO:0031014) |
4.3 | 12.8 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
4.3 | 8.6 | GO:0038132 | neuregulin binding(GO:0038132) |
4.3 | 17.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
4.3 | 12.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
4.3 | 93.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
4.2 | 46.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
4.2 | 4.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
4.2 | 4.2 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
4.2 | 12.6 | GO:0000339 | RNA cap binding(GO:0000339) |
4.2 | 4.2 | GO:0036033 | mediator complex binding(GO:0036033) |
4.2 | 16.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
4.2 | 45.9 | GO:0043176 | amine binding(GO:0043176) |
4.2 | 20.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
4.1 | 78.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
4.1 | 12.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
4.1 | 12.3 | GO:0038100 | nodal binding(GO:0038100) |
4.1 | 57.5 | GO:0005521 | lamin binding(GO:0005521) |
4.1 | 4.1 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
4.1 | 16.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
4.1 | 8.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
4.1 | 24.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
4.1 | 12.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
4.1 | 16.2 | GO:0009374 | biotin binding(GO:0009374) |
4.1 | 24.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
4.0 | 16.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
4.0 | 4.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
4.0 | 8.1 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
4.0 | 8.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
4.0 | 56.2 | GO:0030506 | ankyrin binding(GO:0030506) |
4.0 | 12.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
4.0 | 15.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
4.0 | 23.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
4.0 | 23.7 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
3.9 | 19.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
3.9 | 31.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
3.9 | 31.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
3.9 | 19.5 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
3.9 | 15.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
3.9 | 50.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
3.9 | 3.9 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
3.9 | 69.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
3.9 | 69.5 | GO:0008483 | transaminase activity(GO:0008483) |
3.9 | 7.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
3.8 | 129.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
3.8 | 94.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
3.8 | 30.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
3.8 | 34.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
3.8 | 7.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
3.8 | 22.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
3.7 | 56.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
3.7 | 15.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
3.7 | 37.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
3.7 | 18.7 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
3.7 | 56.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
3.7 | 3.7 | GO:0008142 | oxysterol binding(GO:0008142) |
3.6 | 10.9 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
3.6 | 14.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
3.6 | 32.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
3.6 | 3.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
3.6 | 29.0 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
3.6 | 36.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
3.6 | 18.1 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
3.6 | 18.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
3.6 | 32.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
3.6 | 32.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
3.6 | 14.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
3.6 | 46.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
3.6 | 14.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
3.6 | 25.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
3.6 | 57.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
3.6 | 3.6 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
3.5 | 53.2 | GO:0001848 | complement binding(GO:0001848) |
3.5 | 81.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
3.5 | 14.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
3.5 | 28.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
3.5 | 7.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
3.5 | 45.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
3.5 | 7.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
3.5 | 24.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
3.5 | 17.4 | GO:0016151 | nickel cation binding(GO:0016151) |
3.5 | 10.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
3.5 | 20.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
3.5 | 10.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
3.5 | 10.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
3.5 | 13.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
3.4 | 13.8 | GO:0030911 | TPR domain binding(GO:0030911) |
3.4 | 6.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
3.4 | 24.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
3.4 | 10.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
3.4 | 37.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
3.4 | 10.2 | GO:0055100 | adiponectin binding(GO:0055100) |
3.4 | 6.8 | GO:0050692 | DBD domain binding(GO:0050692) |
3.4 | 10.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
3.4 | 13.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
3.4 | 16.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
3.3 | 16.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
3.3 | 13.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
3.3 | 3.3 | GO:0019862 | IgA binding(GO:0019862) |
3.3 | 13.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
3.3 | 36.5 | GO:0019841 | retinol binding(GO:0019841) |
3.3 | 26.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
3.3 | 118.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
3.3 | 29.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
3.3 | 3.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
3.3 | 144.3 | GO:0019209 | kinase activator activity(GO:0019209) |
3.3 | 9.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
3.3 | 49.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
3.3 | 3.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
3.2 | 90.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
3.2 | 12.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
3.2 | 89.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
3.2 | 35.1 | GO:0017166 | vinculin binding(GO:0017166) |
3.2 | 38.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
3.2 | 12.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
3.2 | 63.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
3.2 | 15.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
3.2 | 31.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
3.2 | 25.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
3.1 | 9.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
3.1 | 25.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
3.1 | 15.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
3.1 | 99.8 | GO:0070888 | E-box binding(GO:0070888) |
3.1 | 12.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
3.1 | 24.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
3.1 | 9.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
3.1 | 9.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
3.1 | 39.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
3.1 | 33.6 | GO:0001618 | virus receptor activity(GO:0001618) |
3.1 | 45.8 | GO:0015923 | mannosidase activity(GO:0015923) |
3.1 | 55.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
3.1 | 42.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
3.0 | 9.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
3.0 | 12.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
3.0 | 3.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
3.0 | 30.3 | GO:0070628 | proteasome binding(GO:0070628) |
3.0 | 39.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
3.0 | 3.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
3.0 | 9.0 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
3.0 | 9.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
3.0 | 41.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
3.0 | 26.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
3.0 | 56.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
3.0 | 5.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
3.0 | 11.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
3.0 | 8.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
3.0 | 8.9 | GO:0002046 | opsin binding(GO:0002046) |
2.9 | 2.9 | GO:0070538 | oleic acid binding(GO:0070538) |
2.9 | 5.9 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
2.9 | 8.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
2.9 | 14.7 | GO:0030955 | potassium ion binding(GO:0030955) |
2.9 | 29.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
2.9 | 37.9 | GO:0008143 | poly(A) binding(GO:0008143) |
2.9 | 70.0 | GO:0052715 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
2.9 | 14.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
2.9 | 8.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.9 | 5.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
2.9 | 14.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
2.9 | 17.3 | GO:1990405 | protein antigen binding(GO:1990405) |
2.9 | 20.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
2.9 | 86.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
2.9 | 8.6 | GO:1990188 | euchromatin binding(GO:1990188) |
2.9 | 5.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
2.8 | 5.7 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
2.8 | 31.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
2.8 | 14.2 | GO:0060590 | ATPase regulator activity(GO:0060590) |
2.8 | 42.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
2.8 | 5.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
2.8 | 11.2 | GO:0048495 | Roundabout binding(GO:0048495) |
2.8 | 69.5 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
2.8 | 22.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
2.8 | 38.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
2.8 | 19.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
2.8 | 5.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
2.8 | 52.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
2.8 | 13.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
2.8 | 8.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
2.8 | 11.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
2.7 | 2.7 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
2.7 | 2.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
2.7 | 13.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
2.7 | 13.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
2.7 | 240.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
2.7 | 10.9 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
2.7 | 21.8 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
2.7 | 8.2 | GO:0043426 | MRF binding(GO:0043426) |
2.7 | 29.9 | GO:0008828 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
2.7 | 59.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
2.7 | 2.7 | GO:0070697 | activin receptor binding(GO:0070697) |
2.7 | 56.8 | GO:0045502 | dynein binding(GO:0045502) |
2.7 | 2.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
2.7 | 10.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
2.7 | 8.0 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
2.7 | 2.7 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
2.7 | 66.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
2.7 | 5.3 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
2.7 | 21.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
2.6 | 18.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
2.6 | 15.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
2.6 | 7.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.6 | 28.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
2.6 | 10.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
2.6 | 15.6 | GO:0045545 | syndecan binding(GO:0045545) |
2.6 | 23.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
2.6 | 7.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.6 | 90.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
2.6 | 18.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.6 | 23.1 | GO:0043022 | ribosome binding(GO:0043022) |
2.6 | 7.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
2.6 | 7.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
2.5 | 12.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
2.5 | 15.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
2.5 | 10.0 | GO:0034584 | piRNA binding(GO:0034584) |
2.5 | 10.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.5 | 70.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
2.5 | 24.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
2.5 | 9.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
2.5 | 2.5 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
2.5 | 27.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
2.5 | 4.9 | GO:0051373 | FATZ binding(GO:0051373) |
2.4 | 9.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
2.4 | 21.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.4 | 14.5 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
2.4 | 14.5 | GO:0090079 | translation activator activity(GO:0008494) translation regulator activity, nucleic acid binding(GO:0090079) |
2.4 | 21.7 | GO:0005123 | death receptor binding(GO:0005123) |
2.4 | 69.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
2.4 | 9.6 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
2.4 | 9.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
2.4 | 4.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
2.4 | 30.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
2.4 | 23.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.4 | 21.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
2.4 | 4.7 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
2.4 | 2.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
2.3 | 30.5 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
2.3 | 14.0 | GO:0008430 | selenium binding(GO:0008430) |
2.3 | 4.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
2.3 | 4.7 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
2.3 | 13.9 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
2.3 | 2.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
2.3 | 6.9 | GO:0016504 | peptidase activator activity(GO:0016504) |
2.3 | 9.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
2.3 | 4.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
2.3 | 20.6 | GO:0004568 | chitinase activity(GO:0004568) |
2.3 | 9.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
2.3 | 6.9 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
2.3 | 32.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
2.3 | 40.9 | GO:0043531 | ADP binding(GO:0043531) |
2.3 | 9.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
2.2 | 20.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
2.2 | 4.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
2.2 | 20.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
2.2 | 161.1 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
2.2 | 35.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
2.2 | 11.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
2.2 | 6.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
2.2 | 8.9 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
2.2 | 118.0 | GO:0051087 | chaperone binding(GO:0051087) |
2.2 | 11.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
2.2 | 31.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
2.2 | 82.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
2.2 | 106.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
2.2 | 22.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
2.2 | 11.0 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
2.2 | 4.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
2.2 | 61.6 | GO:0043621 | protein self-association(GO:0043621) |
2.2 | 24.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
2.2 | 52.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
2.2 | 24.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
2.2 | 4.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
2.2 | 174.4 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
2.2 | 6.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
2.2 | 4.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.2 | 4.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
2.2 | 15.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
2.1 | 10.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
2.1 | 6.4 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
2.1 | 355.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
2.1 | 6.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
2.1 | 27.7 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
2.1 | 14.9 | GO:0050700 | CARD domain binding(GO:0050700) |
2.1 | 4.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
2.1 | 20.9 | GO:0030552 | cAMP binding(GO:0030552) |
2.1 | 10.5 | GO:0017040 | ceramidase activity(GO:0017040) |
2.1 | 4.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
2.1 | 14.5 | GO:0043274 | phospholipase binding(GO:0043274) |
2.1 | 16.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
2.1 | 10.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
2.1 | 70.3 | GO:0004521 | endoribonuclease activity(GO:0004521) |
2.1 | 8.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
2.1 | 26.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
2.1 | 12.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
2.1 | 34.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
2.1 | 8.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
2.0 | 6.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
2.0 | 44.9 | GO:0030145 | manganese ion binding(GO:0030145) |
2.0 | 16.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
2.0 | 12.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
2.0 | 40.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
2.0 | 6.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.0 | 96.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
2.0 | 8.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.0 | 24.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
2.0 | 6.0 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
2.0 | 2.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
2.0 | 4.0 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
2.0 | 7.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
2.0 | 7.9 | GO:0005534 | galactose binding(GO:0005534) |
2.0 | 5.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
2.0 | 7.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
2.0 | 88.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
2.0 | 9.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
2.0 | 3.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
2.0 | 7.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.9 | 44.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.9 | 5.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.9 | 44.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.9 | 234.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
1.9 | 5.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.9 | 32.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
1.9 | 11.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.9 | 9.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.9 | 3.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.9 | 61.2 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
1.9 | 7.7 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
1.9 | 5.7 | GO:0071253 | connexin binding(GO:0071253) |
1.9 | 15.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.9 | 28.6 | GO:0005537 | mannose binding(GO:0005537) |
1.9 | 9.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.9 | 17.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
1.9 | 73.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
1.9 | 1.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.9 | 5.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.9 | 1.9 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
1.9 | 3.8 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.9 | 29.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.9 | 54.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.9 | 9.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.9 | 156.8 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
1.9 | 1.9 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
1.9 | 5.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.8 | 14.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.8 | 5.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.8 | 12.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.8 | 7.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.8 | 7.3 | GO:0000182 | rDNA binding(GO:0000182) |
1.8 | 12.7 | GO:0030371 | translation repressor activity(GO:0030371) |
1.8 | 7.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.8 | 3.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.8 | 7.2 | GO:0070402 | NADPH binding(GO:0070402) |
1.8 | 5.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.8 | 12.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.8 | 26.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
1.8 | 76.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.8 | 16.1 | GO:0039706 | co-receptor binding(GO:0039706) |
1.8 | 21.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.8 | 5.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.8 | 180.1 | GO:0043774 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
1.8 | 5.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
1.8 | 7.0 | GO:0030507 | spectrin binding(GO:0030507) |
1.8 | 12.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
1.7 | 15.7 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.7 | 88.9 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
1.7 | 8.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
1.7 | 34.7 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.7 | 3.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.7 | 3.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.7 | 5.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
1.7 | 5.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.7 | 5.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
1.7 | 3.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.7 | 1.7 | GO:0016895 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
1.7 | 13.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
1.7 | 15.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.7 | 37.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
1.7 | 8.5 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
1.7 | 10.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.7 | 10.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.7 | 3.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.7 | 20.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.7 | 6.8 | GO:0070513 | death domain binding(GO:0070513) |
1.7 | 28.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
1.7 | 8.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.7 | 3.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.7 | 5.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.6 | 1.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.6 | 13.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.6 | 3.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.6 | 4.9 | GO:0035514 | DNA demethylase activity(GO:0035514) |
1.6 | 3.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.6 | 14.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
1.6 | 8.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
1.6 | 1.6 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
1.6 | 4.9 | GO:0019767 | IgE receptor activity(GO:0019767) |
1.6 | 8.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
1.6 | 1.6 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
1.6 | 16.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
1.6 | 27.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.6 | 66.2 | GO:0001047 | core promoter binding(GO:0001047) |
1.6 | 9.7 | GO:0031491 | nucleosome binding(GO:0031491) |
1.6 | 11.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.6 | 6.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.6 | 1.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.6 | 20.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.6 | 3.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
1.5 | 55.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
1.5 | 6.2 | GO:0048038 | quinone binding(GO:0048038) |
1.5 | 3.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.5 | 15.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
1.5 | 4.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.5 | 3.0 | GO:0031433 | telethonin binding(GO:0031433) |
1.5 | 60.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
1.5 | 86.7 | GO:0004519 | endonuclease activity(GO:0004519) |
1.5 | 22.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
1.5 | 4.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.5 | 50.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
1.5 | 5.9 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
1.5 | 2.9 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
1.5 | 5.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
1.5 | 64.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
1.5 | 16.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.5 | 2.9 | GO:0050693 | LBD domain binding(GO:0050693) |
1.5 | 17.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.5 | 197.4 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
1.4 | 4.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.4 | 2.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.4 | 2.9 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.4 | 30.3 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.4 | 63.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.4 | 4.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.4 | 21.5 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
1.4 | 48.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
1.4 | 8.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.4 | 319.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
1.4 | 9.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
1.4 | 2.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.4 | 8.5 | GO:0015266 | protein channel activity(GO:0015266) |
1.4 | 1.4 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
1.4 | 9.8 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
1.4 | 1.4 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
1.4 | 2.8 | GO:0004386 | helicase activity(GO:0004386) |
1.4 | 40.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
1.4 | 4.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.4 | 4.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.4 | 2.8 | GO:0031404 | chloride ion binding(GO:0031404) |
1.4 | 15.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.4 | 1.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.4 | 4.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
1.4 | 1.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
1.4 | 2.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.4 | 56.9 | GO:0000149 | SNARE binding(GO:0000149) |
1.4 | 4.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.4 | 13.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.3 | 5.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.3 | 4.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
1.3 | 22.8 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
1.3 | 37.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.3 | 7.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.3 | 11.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.3 | 7.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.3 | 1.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
1.3 | 6.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.3 | 6.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.3 | 3.9 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.3 | 2.6 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
1.3 | 6.5 | GO:0005522 | profilin binding(GO:0005522) |
1.3 | 3.9 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
1.3 | 1.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.3 | 2.6 | GO:0016530 | metallochaperone activity(GO:0016530) |
1.3 | 5.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.3 | 16.5 | GO:0000049 | tRNA binding(GO:0000049) |
1.3 | 6.3 | GO:0005499 | vitamin D binding(GO:0005499) |
1.3 | 13.9 | GO:0031369 | translation initiation factor binding(GO:0031369) |
1.3 | 1.3 | GO:0051431 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
1.3 | 3.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.3 | 6.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
1.2 | 3.7 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
1.2 | 3.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.2 | 8.7 | GO:0003796 | lysozyme activity(GO:0003796) |
1.2 | 6.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
1.2 | 9.8 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
1.2 | 1.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
1.2 | 17.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.2 | 2.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.2 | 2.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
1.2 | 2.4 | GO:0019864 | IgG binding(GO:0019864) |
1.2 | 1.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.2 | 6.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.2 | 1.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
1.2 | 1.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.2 | 7.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
1.2 | 4.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.2 | 4.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.2 | 2.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.2 | 3.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
1.2 | 1.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.2 | 198.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.1 | 28.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
1.1 | 3.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
1.1 | 1.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.1 | 42.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
1.1 | 5.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.1 | 18.1 | GO:0020037 | heme binding(GO:0020037) |
1.1 | 3.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.1 | 3.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.1 | 1.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.1 | 8.8 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
1.1 | 3.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
1.1 | 9.9 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
1.1 | 10.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
1.1 | 12.0 | GO:0019213 | deacetylase activity(GO:0019213) |
1.1 | 4.3 | GO:0010181 | FMN binding(GO:0010181) |
1.1 | 3.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.1 | 3.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.1 | 4.3 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
1.1 | 3.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.1 | 45.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
1.1 | 3.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
1.1 | 4.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.1 | 3.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.0 | 2.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.0 | 2.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.0 | 7.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.0 | 11.5 | GO:0004175 | endopeptidase activity(GO:0004175) |
1.0 | 18.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
1.0 | 2.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.0 | 2.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
1.0 | 5.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.0 | 6.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.0 | 26.6 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
1.0 | 13.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
1.0 | 4.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.0 | 7.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
1.0 | 10.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
1.0 | 11.1 | GO:0009055 | electron carrier activity(GO:0009055) |
1.0 | 41.1 | GO:0008565 | protein transporter activity(GO:0008565) |
1.0 | 9.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
1.0 | 14.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.0 | 6.0 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.0 | 1.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
1.0 | 14.8 | GO:0042805 | actinin binding(GO:0042805) |
1.0 | 25.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
1.0 | 2.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
1.0 | 198.2 | GO:0005525 | GTP binding(GO:0005525) |
1.0 | 9.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.0 | 1.9 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.0 | 22.3 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
1.0 | 2.9 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
1.0 | 4.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.0 | 1.0 | GO:2001070 | starch binding(GO:2001070) |
1.0 | 1.9 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.9 | 1.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.9 | 2.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.9 | 1.9 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.9 | 2.8 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.9 | 3.7 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.9 | 2.8 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.9 | 0.9 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.9 | 11.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.9 | 2.7 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.9 | 1.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.9 | 17.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.9 | 6.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.9 | 0.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.9 | 2.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.9 | 2.7 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.9 | 2.7 | GO:0045182 | translation regulator activity(GO:0045182) |
0.9 | 8.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.9 | 18.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.9 | 15.6 | GO:0019838 | growth factor binding(GO:0019838) |
0.9 | 3.4 | GO:0016209 | antioxidant activity(GO:0016209) |
0.9 | 2.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.9 | 1.7 | GO:0051379 | epinephrine binding(GO:0051379) |
0.8 | 0.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.8 | 22.0 | GO:0042562 | hormone binding(GO:0042562) |
0.8 | 22.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.8 | 3.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.8 | 0.8 | GO:0008061 | chitin binding(GO:0008061) |
0.8 | 0.8 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.8 | 3.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.8 | 1.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.8 | 2.5 | GO:2001069 | glycogen binding(GO:2001069) |
0.8 | 76.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.8 | 1.6 | GO:0035197 | siRNA binding(GO:0035197) |
0.8 | 87.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.8 | 6.5 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.8 | 4.9 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.8 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.8 | 5.7 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.8 | 18.6 | GO:0003823 | antigen binding(GO:0003823) |
0.8 | 2.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.8 | 532.6 | GO:0003723 | RNA binding(GO:0003723) |
0.8 | 18.3 | GO:0042393 | histone binding(GO:0042393) |
0.8 | 1.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.8 | 0.8 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.8 | 0.8 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.8 | 14.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.8 | 1.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.8 | 1.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.8 | 5.3 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.8 | 4.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.8 | 1.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.7 | 26.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.7 | 27.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.7 | 131.5 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.7 | 0.7 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.7 | 2.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.7 | 65.7 | GO:0005550 | pheromone binding(GO:0005550) |
0.7 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.7 | 12.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.7 | 5.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.7 | 0.7 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.7 | 1.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.7 | 1.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.7 | 10.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.7 | 2.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.7 | 0.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.7 | 11.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.7 | 1.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.7 | 3.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 5.9 | GO:0002039 | p53 binding(GO:0002039) |
0.6 | 1.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.6 | 3.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.6 | 1.9 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.6 | 0.6 | GO:0035173 | histone kinase activity(GO:0035173) |
0.6 | 3.2 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.6 | 1.9 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.6 | 3.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.6 | 1.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.6 | 1.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.6 | 0.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.6 | 11.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.6 | 1.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.6 | 11.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.6 | 40.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.6 | 0.6 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.6 | 6.0 | GO:0019955 | cytokine binding(GO:0019955) |
0.6 | 3.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.6 | 1.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.6 | 0.6 | GO:0019863 | IgE binding(GO:0019863) |
0.6 | 12.4 | GO:0002020 | protease binding(GO:0002020) |
0.6 | 7.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.6 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.6 | 1.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.6 | 2.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 1.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.6 | 29.7 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.6 | 0.6 | GO:0015927 | trehalase activity(GO:0015927) |
0.6 | 3.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.6 | 7.7 | GO:0008144 | drug binding(GO:0008144) |
0.5 | 1.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.5 | 8.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 0.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.5 | 2.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.5 | 5.8 | GO:0017022 | myosin binding(GO:0017022) |
0.5 | 0.5 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.5 | 1.6 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.5 | 0.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.5 | 0.5 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.5 | 8.3 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.5 | 7.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.5 | 1.5 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.5 | 1.0 | GO:0015928 | fucosidase activity(GO:0015928) |
0.5 | 1.5 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.5 | 82.3 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.5 | 1.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 56.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.5 | 4.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.5 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 30.9 | GO:0003774 | motor activity(GO:0003774) |
0.4 | 13.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 3.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 7.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 0.8 | GO:0048185 | activin binding(GO:0048185) |
0.4 | 1.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 9.0 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.4 | 13.2 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.4 | 0.8 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.4 | 0.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 1.9 | GO:0031386 | protein tag(GO:0031386) |
0.4 | 0.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 1.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.4 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 12.2 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 0.3 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.3 | 1.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 0.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 22.0 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.3 | 2.3 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.3 | 1.6 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.3 | 0.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 1.5 | GO:0004518 | nuclease activity(GO:0004518) |
0.3 | 3.4 | GO:0051020 | GTPase binding(GO:0051020) |
0.3 | 0.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 1.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 7.9 | GO:0044325 | ion channel binding(GO:0044325) |
0.3 | 1.1 | GO:0016594 | glycine binding(GO:0016594) |
0.3 | 13.2 | GO:0019902 | phosphatase binding(GO:0019902) |
0.3 | 97.3 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.3 | 0.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 2.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 270.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.2 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 4.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 4.5 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 0.2 | GO:0005501 | retinoid binding(GO:0005501) |
0.2 | 94.4 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 21.9 | GO:0042803 | protein homodimerization activity(GO:0042803) |
0.2 | 47.2 | GO:0046914 | transition metal ion binding(GO:0046914) |
0.2 | 0.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 3.0 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.2 | 3.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 1.8 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.2 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 2.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 15.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 1.9 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.1 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.3 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.0 | 0.0 | GO:1901338 | catecholamine binding(GO:1901338) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.4 | 67.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
8.1 | 113.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
6.7 | 168.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
6.3 | 175.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
5.9 | 5.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
5.8 | 181.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
5.7 | 62.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
5.7 | 340.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
5.7 | 101.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
5.0 | 20.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
4.6 | 46.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
4.4 | 139.2 | PID INSULIN PATHWAY | Insulin Pathway |
4.3 | 12.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
4.2 | 154.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
4.1 | 66.1 | PID ARF 3PATHWAY | Arf1 pathway |
4.1 | 12.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
4.0 | 32.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
4.0 | 104.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
4.0 | 28.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
4.0 | 130.5 | PID RHOA PATHWAY | RhoA signaling pathway |
3.8 | 130.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
3.8 | 65.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
3.8 | 11.5 | PID IGF1 PATHWAY | IGF1 pathway |
3.8 | 15.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
3.8 | 94.5 | PID AURORA A PATHWAY | Aurora A signaling |
3.7 | 108.1 | PID LKB1 PATHWAY | LKB1 signaling events |
3.7 | 25.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
3.7 | 55.2 | PID BARD1 PATHWAY | BARD1 signaling events |
3.7 | 73.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
3.6 | 25.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
3.5 | 3.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
3.5 | 3.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
3.5 | 169.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
3.5 | 141.9 | PID P53 REGULATION PATHWAY | p53 pathway |
3.4 | 72.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
3.4 | 13.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
3.4 | 61.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
3.4 | 67.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
3.4 | 165.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
3.3 | 82.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
3.3 | 32.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
3.3 | 62.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
3.2 | 25.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
3.2 | 143.0 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
3.1 | 6.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
3.0 | 6.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
3.0 | 108.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
3.0 | 24.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
3.0 | 62.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.9 | 49.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
2.8 | 36.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
2.7 | 29.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
2.7 | 10.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
2.7 | 16.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.7 | 26.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
2.7 | 122.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
2.6 | 20.6 | PID FOXO PATHWAY | FoxO family signaling |
2.6 | 20.5 | ST GAQ PATHWAY | G alpha q Pathway |
2.5 | 35.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
2.5 | 170.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
2.4 | 19.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
2.4 | 34.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
2.4 | 9.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
2.4 | 60.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
2.4 | 7.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
2.4 | 29.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
2.4 | 23.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
2.4 | 40.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
2.4 | 59.5 | PID AURORA B PATHWAY | Aurora B signaling |
2.4 | 28.4 | PID ATM PATHWAY | ATM pathway |
2.3 | 23.4 | PID ARF6 PATHWAY | Arf6 signaling events |
2.3 | 11.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
2.3 | 16.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
2.3 | 15.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
2.3 | 22.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
2.3 | 15.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
2.2 | 30.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
2.2 | 21.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
2.2 | 25.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
2.1 | 37.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
2.1 | 33.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
2.0 | 12.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
2.0 | 16.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.0 | 37.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
2.0 | 4.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
2.0 | 45.5 | PID PLK1 PATHWAY | PLK1 signaling events |
2.0 | 41.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
2.0 | 21.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.9 | 7.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.9 | 5.7 | PID IFNG PATHWAY | IFN-gamma pathway |
1.9 | 21.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.8 | 18.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.8 | 20.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.8 | 51.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
1.8 | 34.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
1.8 | 34.5 | PID E2F PATHWAY | E2F transcription factor network |
1.8 | 21.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.8 | 8.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.8 | 10.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.8 | 1.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
1.8 | 10.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.7 | 15.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
1.7 | 10.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.7 | 1.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.7 | 18.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.7 | 5.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.7 | 13.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.7 | 23.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
1.7 | 3.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.6 | 24.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
1.6 | 40.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.5 | 13.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.5 | 11.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
1.4 | 25.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
1.4 | 4.2 | PID SHP2 PATHWAY | SHP2 signaling |
1.4 | 4.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.3 | 16.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
1.3 | 22.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.3 | 3.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
1.3 | 2.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.3 | 6.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
1.2 | 8.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.2 | 13.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.1 | 2.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.1 | 28.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.1 | 16.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.0 | 8.1 | PID BCR 5PATHWAY | BCR signaling pathway |
1.0 | 4.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.0 | 13.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.0 | 13.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.0 | 1.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.0 | 13.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.0 | 1.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.9 | 0.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.9 | 0.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.9 | 7.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.8 | 6.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.8 | 10.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.8 | 146.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.7 | 23.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.7 | 3.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.7 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.7 | 2.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.7 | 8.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.7 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 11.4 | PID P73PATHWAY | p73 transcription factor network |
0.6 | 2.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.6 | 1.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.6 | 15.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.6 | 4.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 73.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 2.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.5 | 1.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.5 | 8.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 5.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 4.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.3 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 3.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.3 | 2.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 8.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 2.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 2.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 16.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 5.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.9 | 215.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
16.5 | 16.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
13.4 | 188.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
12.2 | 122.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
9.7 | 9.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
9.6 | 134.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
9.2 | 91.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
8.9 | 35.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
8.8 | 96.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
8.1 | 81.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
7.8 | 163.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
7.6 | 30.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
7.5 | 75.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
7.5 | 128.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
7.4 | 111.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
7.3 | 14.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
6.7 | 86.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
6.5 | 65.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
6.5 | 51.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
6.4 | 141.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
6.3 | 95.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
6.1 | 72.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
5.7 | 90.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
5.7 | 79.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
5.6 | 5.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
5.5 | 127.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
5.5 | 44.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
5.4 | 16.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
5.3 | 142.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
5.2 | 141.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
5.2 | 67.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
5.1 | 96.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
5.0 | 10.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
5.0 | 54.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
4.9 | 39.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
4.9 | 19.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
4.8 | 183.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
4.7 | 75.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
4.6 | 46.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
4.6 | 4.6 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
4.4 | 39.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
4.4 | 44.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
4.4 | 13.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
4.3 | 69.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
4.3 | 38.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
4.2 | 101.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
4.0 | 80.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
4.0 | 40.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
4.0 | 8.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
4.0 | 23.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
3.9 | 7.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
3.9 | 31.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
3.9 | 102.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
3.9 | 7.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
3.9 | 171.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
3.9 | 31.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
3.9 | 89.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
3.9 | 104.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
3.9 | 62.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
3.8 | 92.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
3.8 | 30.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
3.8 | 110.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
3.8 | 41.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
3.7 | 18.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
3.7 | 70.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
3.7 | 55.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
3.7 | 33.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
3.7 | 55.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
3.7 | 7.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
3.6 | 10.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
3.6 | 61.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
3.6 | 28.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
3.6 | 21.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
3.6 | 32.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
3.5 | 38.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
3.5 | 21.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
3.5 | 21.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
3.5 | 38.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
3.5 | 51.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
3.4 | 99.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
3.4 | 33.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
3.4 | 23.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
3.4 | 13.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
3.3 | 123.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
3.3 | 23.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
3.3 | 40.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
3.3 | 118.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
3.2 | 9.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
3.2 | 42.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
3.2 | 70.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
3.2 | 22.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
3.2 | 41.0 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
3.1 | 28.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
3.1 | 254.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
3.1 | 12.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
3.1 | 31.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
3.0 | 3.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
3.0 | 6.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
3.0 | 6.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
3.0 | 48.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
3.0 | 56.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
3.0 | 32.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.9 | 14.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
2.9 | 32.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
2.9 | 55.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
2.9 | 17.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
2.8 | 62.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
2.8 | 25.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
2.8 | 11.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
2.8 | 11.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
2.8 | 27.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
2.7 | 71.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
2.7 | 27.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
2.7 | 24.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
2.7 | 38.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
2.7 | 13.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.7 | 54.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
2.7 | 43.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
2.7 | 26.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.7 | 31.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
2.6 | 68.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
2.6 | 39.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
2.6 | 5.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
2.6 | 2.6 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
2.6 | 36.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
2.6 | 15.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
2.5 | 15.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.5 | 20.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
2.5 | 65.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
2.5 | 90.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
2.5 | 22.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
2.4 | 16.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
2.4 | 21.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
2.4 | 127.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
2.4 | 9.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
2.4 | 4.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
2.4 | 30.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
2.3 | 25.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
2.3 | 16.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.2 | 17.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
2.2 | 176.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
2.2 | 26.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.2 | 10.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
2.2 | 21.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
2.1 | 23.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
2.1 | 38.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
2.1 | 10.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
2.1 | 29.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
2.1 | 8.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
2.1 | 29.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
2.1 | 22.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
2.1 | 22.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
2.0 | 14.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
2.0 | 2.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
2.0 | 18.0 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
2.0 | 14.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
2.0 | 35.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.9 | 54.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.9 | 19.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.9 | 192.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
1.9 | 28.8 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.9 | 11.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
1.9 | 31.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.8 | 38.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
1.8 | 20.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.8 | 3.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.8 | 5.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.8 | 45.2 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
1.8 | 51.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.8 | 33.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.7 | 40.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
1.7 | 48.6 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
1.7 | 108.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
1.7 | 3.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.7 | 25.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
1.7 | 5.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
1.7 | 78.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.7 | 3.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.7 | 18.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.7 | 24.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.6 | 62.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.6 | 9.9 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
1.6 | 44.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.6 | 6.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.6 | 32.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
1.6 | 19.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
1.5 | 43.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.5 | 33.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.4 | 7.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.4 | 7.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
1.4 | 41.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.4 | 21.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.4 | 8.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
1.4 | 2.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.4 | 5.7 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
1.4 | 112.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
1.4 | 26.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
1.4 | 83.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.3 | 1.3 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
1.3 | 203.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
1.3 | 75.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
1.3 | 19.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
1.3 | 19.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.3 | 10.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
1.3 | 21.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
1.2 | 76.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
1.2 | 18.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
1.2 | 2.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
1.1 | 9.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.1 | 3.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
1.1 | 3.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.1 | 35.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
1.0 | 68.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.0 | 3.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.0 | 9.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.9 | 12.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.9 | 0.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.9 | 4.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.9 | 14.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.9 | 2.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.8 | 1.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.8 | 31.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 15.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.7 | 2.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.7 | 6.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.7 | 3.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.7 | 73.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.7 | 4.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.7 | 7.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.6 | 10.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 13.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.6 | 3.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.6 | 8.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.5 | 3.2 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.5 | 27.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.5 | 16.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.5 | 7.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.5 | 3.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.5 | 9.8 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.5 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 7.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 4.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 3.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 1.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.3 | 4.7 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.3 | 3.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 12.6 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.3 | 20.1 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |
0.3 | 1.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 1.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.3 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 0.9 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.3 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 0.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 0.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 0.2 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.2 | 1.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 2.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 1.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.5 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.2 | 3.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.3 | REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | Genes involved in SLC-mediated transmembrane transport |
0.1 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |